University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2016

Linking Acetyl-Coa Metabolism and Histone Acetylation to
Dynamic Gene Regulation in Yeast and Mouse Hippocampus
Philipp Mews
University of Pennsylvania, philipp.mews@gmail.com

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Genetics Commons, Molecular Biology Commons, and the Neuroscience and Neurobiology
Commons

Recommended Citation
Mews, Philipp, "Linking Acetyl-Coa Metabolism and Histone Acetylation to Dynamic Gene Regulation in
Yeast and Mouse Hippocampus" (2016). Publicly Accessible Penn Dissertations. 1895.
https://repository.upenn.edu/edissertations/1895

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1895
For more information, please contact repository@pobox.upenn.edu.

Linking Acetyl-Coa Metabolism and Histone Acetylation to Dynamic Gene
Regulation in Yeast and Mouse Hippocampus
Abstract
A compelling body of evidence suggests an intimate relationship between metabolic state and chromatin
regulation. This link is manifested in key metabolites that participate in biochemical pathways as
intermediates, and function as cofactors to regulate chromatin modifying enzymes. Of particular interest
is the metabolite acetyl-CoA, given its central role as an intermediate of cellular energy metabolism and
key determinant of all histone acetylation. How nuclear acetyl-CoA levels are regulated to, in turn, control
histone acetylation is under intense investigation, and holds promise for increased understanding of the
molecular mechanisms adapting gene expression to internal and external stimuli. We studied the
relationship between histone modification dynamics and the dramatic transcriptional changes that occur
during nutrient‐induced cell cycle re-entry from quiescence in the yeast S. cerevisiae. ChIP‐seq and
SILAC-based mass spec revealed genome‐wide shifts in histone acetylation at growth and stress genes
as cells exit quiescence and transcription dramatically changes. Strikingly, however, the patterns of
histone methylation remain intact. We conclude that histone acetylation, in contrast to methylation,
rapidly responds to metabolic state, driving growth gene transcription in nutrient-induced cell cycle reentry. Next, we set out to investigate how nuclear acetyl-CoA is regulated to control histone acetylation in
mammalian cells. We reveal a previously unknown function of the central metabolic enzyme acetyl-CoA
synthetase 2 (ACSS2) as a chromatin-bound transcriptional coactivator that stimulates histone
acetylation and gene expression. We show that ACSS2 is a critical and direct regulator of histone
acetylation in neurons and of long-term mammalian memory. Genome-wide, ACSS2 binding corresponds
with increased histone acetylation and gene expression of key neuronal genes. Our data indicate that
ACSS2 functions as a chromatin-bound co-activator to increase local concentrations of acetyl-CoA, to
locally promote histone acetylation for transcription of neuron-specific genes. Remarkably, in vivo
attenuation of hippocampal ACSS2 expression in adult mice impairs long-term spatial memory, a
cognitive process reliant on histone acetylation. ACSS2 reduction in hippocampus also leads to a defect
in upregulation of key neuronal genes involved in memory. These findings reveal a unique connection
between cellular metabolism and neural plasticity, and establish a link between generation of acetyl-CoA
and neuronal chromatin regulation.
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ABSTRACT
LINKING ACETYL-COA METABOLISM AND HISTONE ACETYLATION
TO DYNAMIC GENE REGULATION IN YEAST AND MOUSE HIPPOCAMPUS
Philipp Mews
Shelley L. Berger

A compelling body of evidence suggests an intimate relationship between metabolic state
and chromatin regulation. This link is manifested in key metabolites that participate in biochemical
pathways as intermediates, and function as cofactors to regulate chromatin modifying enzymes.
Of particular interest is the metabolite acetyl-CoA, given its central role as an intermediate of
cellular energy metabolism and key determinant of all histone acetylation. How nuclear acetylCoA levels are regulated to, in turn, control histone acetylation is under intense investigation, and
holds promise for increased understanding of the molecular mechanisms adapting gene
expression to internal and external stimuli. We studied the relationship between histone
modification dynamics and the dramatic transcriptional changes that occur during nutrient‐
induced cell cycle re-entry from quiescence in the yeast S. cerevisiae. ChIP‐seq and SILACbased mass spec revealed genome‐wide shifts in histone acetylation at growth and stress genes
as cells exit quiescence and transcription dramatically changes. Strikingly, however, the patterns
of histone methylation remain intact. We conclude that histone acetylation, in contrast to
methylation, rapidly responds to metabolic state, driving growth gene transcription in nutrientinduced cell cycle re-entry. Next, we set out to investigate how nuclear acetyl-CoA is regulated to
control histone acetylation in mammalian cells. We reveal a previously unknown function of the
central metabolic enzyme acetyl-CoA synthetase 2 (ACSS2) as a chromatin-bound transcriptional
coactivator that stimulates histone acetylation and gene expression. We show that ACSS2 is a
critical and direct regulator of histone acetylation in neurons and of long-term mammalian
memory. Genome-wide, ACSS2 binding corresponds with increased histone acetylation and gene
iii

expression of key neuronal genes. Our data indicate that ACSS2 functions as a chromatin-bound
co-activator to increase local concentrations of acetyl-CoA, to locally promote histone acetylation
for transcription of neuron-specific genes. Remarkably, in vivo attenuation of hippocampal ACSS2
expression in adult mice impairs long-term spatial memory, a cognitive process reliant on histone
acetylation. ACSS2 reduction in hippocampus also leads to a defect in upregulation of key
neuronal genes involved in memory. These findings reveal a unique connection between cellular
metabolism and neural plasticity, and establish a link between generation of acetyl-CoA and
neuronal chromatin regulation.
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CHAPTER 1
INTRODUCTION
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ABOVE AND BEYOND: EPIGENETICS
The term epigenetics was coined by Waddington to describe a conceptual solution to a
fundamental consideration – and conundrum – in developmental biology1. All the different types
of cells that make up our bodies, bar certain exceptions in our reproductive and immune systems,
have exactly the same genome. Hence, our muscle cells contain the exact same DNA nucleotide
sequence as our brain cells. Therefore, a key question is how can the identical DNA template
yield distinct cell types like myocytes or neurons? How can two cells have the exact same DNA
but produce vastly different gene products? Waddington reasoned there must be a mechanism
above the level of DNA that controls the readout of genes encoded in its nucleotide sequence –
coining the term epigenetics. These epigenetic mechanisms specify certain sets of genes that are
turned into functional products in neurons, for instance, yet not in myocytes. Diverse epigenetic
marks are set up during early cell fate decisions, in due course forming a cellular memory system
that perpetuates cellular phenotypes over the lifespan of our bodies. In view of that, classic
epigenetics is the study of a change in gene expression or cellular phenotype that is stably
inherited by a cell and that is not associated with changes in DNA sequence 2 (Fig. 1.1).

Figure 1.1. Waddington’s epigenetic landscape
Conrad Waddington used the concept of the epigenetic landscape to describe the process by which a cell,
pictured here as a ball, may follow many different paths of differentiation during development. (Waddington,
1957)1
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Recent years have seen spectacular advances in the field of epigenetics, and additional
aspects of epigenetic control keep emerging that extend its modern definition. These qualities
transcend the mechanisms that hard-wire phenotypes at the cellular level during development,
and further implicate them in the acute regulation of dynamic gene expression that must be
adapted to the ever-changing cellular environment. It is through epigenetic mechanisms that the
relatively fixed genetic blueprint can flexibly accommodate variability resulting from environmental
stimuli, dietary signals, and other influences. Remarkably, epigenetic regulation is not only critical
for basic cellular processes such as neuronal plasticity, but is now being recognized to play
important congruent roles in highly complex behaviors such as learning and memory3,4.

Figure 1.2. Atomic structure of the core histones and nucleosome.
(A) A tetramer of H3 (green) and H4 (yellow). (B) A dimer of H2A (red) and H2B (pink). (C) Nucleosome core
particle. Each strand of DNA is shown in a different shade of blue. The DNA makes 1.7 turns around the
histone octamer to form an overall particle with a disk-like structure. Histones are colored as in (A) and (B).
(adapted from Khorasanizadeh, 2004)5
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Although many cellular phenomena may be considered epigenetic, the primary focus of
the field has been to illuminate the mechanistic layers that underlie environment-genome
interaction at the level of chromatin. Chromatin is referred to as the DNA-protein packaging
complex that determines the accessibility of DNA in eukaryotic cells, making it the focal point of
transcriptional gene regulation. The basic repeating unit of the chromatin structure is the
nucleosome: ~146 base pairs (bp) of genomic DNA wrapped around a protein octamer,
assembled from two molecules each of histone H2A, H2B, H3, and H4 (Fig. 1.2). In essence, the
nucleosome constitutes a platform for complex chemical modifications – i.e. epigenetic marks –
that dynamically regulate chromatin architecture and gene transcription 6. The entirety of these
epigenetic features has been denoted the epigenome – it defines cellular identity and expresses
the regulatory channels that operate at the interface of genome and environment.

Figure 1.3. Post-translational modifications of histone proteins
The modifications include acetylation (ac), methylation (me), phosphorylation (ph) and ubiquitination (ub1).
Most of the known histone modifications occur on the N-terminal tails of histones, with some exceptions
including ubiquitination of the C-terminal tails of H2A and H2B and acetylation and methylation of the globular
domain of H3 at K56 and K79, respectively. Globular domains of each core histone are represented as colored
ovals. (from Bhaumik et al., 2007)7
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Post-translational modifications of histones elicit structural and functional changes within
chromatin and regulate various epigenetic processes. Numerous histone modifications have been
identified and include acetylation, methylation, phosphorylation, ubiquitylation, sumoylation, and
ADP-ribosylation6,8 (Fig. 1.3). Acetylation, for instance, along with methylation, is the most
extensively studied histone modification, and has broad effects on chromatin function and nuclear
signaling pathways9,10. Histone acetylation marks are written by histone acetyltransferases
(HATs). These enzymes acetylate specific lysine residues of histone proteins, which neutralizes
their positive charge, and can thus help to de-condense chromatin leading to active gene
transcription10. Additionally, histone acetylation marks can be bound by small protein modules
called bromodomains, often referred to as ‘readers’. These domains are conserved within many
chromatin-associated proteins – including HATs themselves – that regulate transcriptionmediated biological processes (Fig. 1.4), and whose aberrant activities are correlated with several
human diseases11–13. Insight into the kinetic mechanisms of the writers, readers, and erasers of
chromatin modifications is anticipated to provide us with novel clinically relevant diagnostic,
prognostic, and therapeutic avenues in the treatment of disease, including cancer and
neurodegenerative disorders.

Figure 1.4. Model for transcriptional activation and repression
(A) In the off state, the DNA-bound repressor (REP) at the upstream repressor site (URS) recruits negative
modifiers, such as histone deacetylases (HDAC), which remove acetyl groups from histones. (B) In the on
state, DNA-bound activator (ACT) at the upstream activator site (UAS) recruits positive modifiers, such as
histone acetylases (HAT). Early during elongation, the C-terminal domain (CTD) of the RNA polymerase (POL)
is phosphorylated at serine 5, leading to recruitment of the COMPASS complex (Set1, part of the COMPASS
complex, methylates H3K4) and DOT1 (which methylates H3K79). Later in elongation the CTD repeat is
phosphorylated at serine 2 (S2ph), which recruits Set2 (H3K36 methylase enzyme). (from Berger, 2007)6
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AT THE NEXUS OF METABOLIC STATE AND CHROMATIN STRUCTURE
The intimate relationship between metabolic state and chromatin regulation has gained
major interest in the field of epigenetics. Cells must continually adapt to metabolic needs and
changing environment, and therefore require an acutely responsive system that adjusts chromatin
structure and gene transcription to maintain homeostasis. Metabolic homeostasis is maintained
by an intricate regulatory circuitry, controlled to a large extent by transcriptional 14–17. In recent
years, a new paradigm of transcriptional regulation has emerged, based on direct sensing of
intermediary metabolites by chromatin-modifying enzymes15,18. Key metabolites, beside their role
in central biochemical pathways as intermediates, also participate as cofactors in chromatin
modification, and can therefore dynamically adapt global chromatin structure and gene
expression to metabolic change19 (Fig. 1.5). Advancing our insight into how metabolic state
influences chromatin structure thus holds promise for new intervention points in the treatment of
diseases that are characterized by epigenetic aberration, including cancer and neurodegenerative
disorders. Hence, metabolic pathways and the enzymes that provide metabolites used in
chromatin modification have now moved into the limelight of epigenetic studies. In particular, the
temporal turnover dynamics of histone modifications – and their dysregulation upon nutritional
and metabolic disruption – are of increasing interest.
The endeavor of exploring the dynamic relationship between cellular metabolism and
chromatin structure, however, is challenged by technological limitations. The advent of chromatin
immunoprecipitation sequencing (ChIP-seq) technology truly revolutionized the field of
epigenetics20–22, and has become the prevalent method to interrogate the genome-wide binding
pattern of epigenetic enzymes and their cognate chromatin modifications. In the past decade, a
wave of epigenomic analyses using ChIP-seq generated maps of the epigenetic landscape that
greatly expanded our knowledge of chromatin structure and its aberrations in disease. Yet, this
now routine method fails to capture important dynamic aspects in epigenetic regulation. Thus, in
order to examine how cellular metabolism regulates dynamic change in chromatin structure, we
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devised a highly adaptable approach that employs two complementary methods: making use of
both high throughput sequencing data to establish the location of changes, and stable isotope
tracing using mass spectrometry to evaluate their dynamics.

Figure 1.5. Chromatin-remodeling enzymes ‘sense’ cellular metabolism
Homeostatic transcriptional responses are induced by changes in nutrition or fluctuations in metabolism. The
enzymatic activity of chromatin-associated proteins is changed in a dose-dependent manner by several
intermediary metabolism products. ‘Writer’ enzymes that attach marks covalently to chromatin or DNA and
‘erasers’ that remove these modifications act as metabolic sensors. Chromatin modifications remodel DNA–
histone interactions and regulate the recruitment of transcriptional complexes to genes that control cellular
function. DNMT, DNA methyltransferases; FAD, flavin adenine dinucleotide; HDACs, histone deacetylases;
HMTs, histone methyltransferases; KATs, lysine acetyltransferases; KDMs, lysine demethylases; O-GlcNAc,
O-linked N-acetylglucosamine; OGT, O-GlcNAc transferase; OGA, O-GlcNAcase; β-OHB, β-hydroxybutyrate;
SAM, S-adenosylmethionine; TET, ten-eleven translocation protein. (from Gut and Verdin, 2013)19
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Figure 1.6. Methodology of SILAC-mass spec analysis of histone modification dynamics
Cells are transferred to medium containing heavy [ 13C]D3-methionine-labeled medium, and isotope
incorporation (orange) into histone methylation pools is monitored over time by tandem mass spectrometry
analysis. Specific shifts in the mass-to-charge (m/z) ratio are used to distinguish unlabeled from labeled
modifications and reveal methylation turnover when measured over time (e.g. 4-Da shift per methyl group).

Quantitative proteomics using Stable Isotope Labeling using Amino acids in Cell culture
(SILAC) is a popular quantitative proteomics approach that relies on the endogenous translational
machinery of living cells to incorporate tagged chemical analogs of molecular building blocks into
chromatin23,24. In the classical SILAC experiment, two cell populations are compared24. These
populations are grown in different media containing distinct forms of amino acids that are either of
natural isotopic abundance or heavy labeled stable isotopes. Incorporation of these light and
heavy amino acids into de novo synthesized proteins creates proteomes that can be discerned by
their specific mass differences. Mass spectrometry is used to measure the relative abundance of
light and heavy peptides in pooled samples, which allows for the detection and quantification of
differential changes in protein expression. In order to study temporal turnover dynamics of
chromatin modifications, we adapted the classic SILAC approach to analyze site-specific
dynamics of different histone modifications25. Our labeling approach provides an effective marker
to distinguish pre-existing from newly catalyzed chromatin modifications, and permits the
monitoring over time for dynamic turnover, when coupled with advanced quantitative liquid
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chromatography-mass spec technology26,27 (Fig. 1.6). Quantitative modeling allowed us to
characterize the steady-state kinetics of histone modifications globally – thus providing a sensitive
metric to study gene regulatory mechanisms in different physiological and metabolic states.
SILAC-based mass spec technology provides sought-after insight into the residuespecific turnover dynamics of histone modifications. These turnover dynamics remain obscured in
classic Western blot analysis that measures only the total relative abundance of specific histone
modifications. SILAC therefore presents a valuable tool to reveal whether particular modification
pools acutely respond to altered metabolic flux. However, neither SILAC nor Western blot
approaches illuminate the genome-wide distribution of the examined histone modifications.
Therefore, in order to monitor epigenomic change over time, the genome-wide enrichment of
histone modifications needs to be investigated with modern ChIP-sequencing technology. Such
insight into the epigenetic landscape by ChIP-seq is critical when examining chromatin-based
mechanisms of gene regulation. For instance, changes in gene expression can result from
metabolic activities that alter the turnover of particular histone modifications. Monitoring turnover
using SILAC-mass spec may indicate whether particular histone modifications are created de
novo, but ChIP-seq is needed to gain insight into their genomic location in order to distinguish (1)
localized dynamic turnover from (2) epigenomic restructuring that involves regional gains and
losses, both of which may be coupled to altered gene expression, as outlined in Figure 1.7.
Likewise, increases in global histone acetylation and methylation may be detected by either
Western blot or SILAC analysis, but only ChIP-sequencing provides information regarding their
genomic location, and whether such change is linked to altered gene expression (Figure 1.7.E
and F). Therefore, SILAC-mass spec and ChIP-seq technologies are especially powerful when
applied together, and work in concert to afford novel insight into chromatin-mediated mechanisms
of transcriptional control by metabolic state.

9

A
b

b

B

c

c

d

d

e

e

f

f

C

D

E

F

Figure 1.7. SILAC-mass spec and ChIP-seq work synergistically to capture dynamic aspects of
chromatin-mediated gene regulation
(A) Hypothetical Western blot analysis of global histone modification levels for theoretical chromatin state
alterations illustrated in B-F (from black to grey), demonstrating the inherent limitations of Western method
when a dynamic change in chromatin structure is analyzed. (B-D) Enrichment of a histone modification over
the promoter region of a gene. Shifts in metabolic state may alter the turnover dynamics of particular histone
modifications, coupled to changes in gene expression. Whereas SILAC-mass spec analysis indicates whether
or not histone modifications are created de novo (example B vs. C, D), this method on its own is inadequate
to distinguish localized dynamic turnover (example C) from epigenomic restructuring involving both regional
gains and losses of enrichment (example D). These outcomes can be distinguished by ChIP-seq, which
provides important information on the genomic location of histone modifications. Conversely, ChIP-seq does
not yield insight into their turnover dynamics that may respond to metabolic state (example B vs. C). Notably,
none of these changes in chromatin structure can be detected by classic Western blot analysis (in A, a-d are
identical levels). (E, F) Increases in total abundance of histone modification may be detected with either
Western or SILAC analysis. Yet, only ChIP-seq technology may determine the location of such epigenetic
change, and whether it is associated with altered gene transcription.
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One context in which a combined approach of SILAC and ChIP-seq is poised to yield
novel insight are studies of oncogenic lesions and the metabolic adaptations they precipitate,
which ultimately alter chromatin structure and epigenome. For instance, in many cancers,
deregulated metabolism resulting in aberrant histone methylation has been implicated in
tumorigenesis28–30. Specifically, mutations in the metabolic enzymes isocitrate dehydrogenase 1
and 2 are found in a variety of tumors and cause neomorphic catalytic activities that generate 2hydroxyglutarate, an oncometabolite that alters the histone methylation landscape and disrupts
regulated gene expression31. Similarly, a large body of evidence has shown that acetyl-CoA
metabolism and histone acetylation are frequently dysregulated in cancer 32,33. Therefore, in order
to develop novel therapeutic approaches that target cellular metabolism to alter the tumor
epigenome, it is key to understand how chromatin is regulated by metabolic state in health and
disease. Our two-pronged approach is of particular advantage when interrogating how such
metabolic and oncogenic mutations influence the dynamic relationship between metabolism,
nutritional environment, and chromatin regulation.

CHROMATIN: A BONA-FIDE ENERGY SENSOR?
Cells constantly sense and integrate environmental cues to maintain homeostasis and
control proliferative growth. In response to unfavorable environmental conditions such as nutrient
depletion, eukaryotic cells enter a resting state termed quiescence. Nutrient availability stimulates
the return into the cell cycle and initiates a growth response that involves histone acetylation and
dramatic change in gene expression (Fig. 1.8). We applied the SILAC and ChIP-seq technologies
described above to study metabolically controlled gene regulation in the context of nutrientinduced growth and cell cycle re-entry from quiescence in the yeast Saccharomyces cerevisiae27.
Budding yeast, providing a flexible and rapid genetic system, has proved to be an excellent model
organism for studying such cellular events34–36. In both mammalian and yeast cells, histone
acetylation – key modulator of transcriptional activation and elongation – has been found to be
exquisitely responsive to the cellular nutritional and metabolic states37–39. Accordingly, acetylation
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can be considered an energy-sensitive protein modification that integrates a range of nutrient
signals to reprogram transcription. However, the genome-wide pattern of glucose-induced histone
acetylation have not been examined, and the roles of targeted and untargeted acetylation in the
transcriptional response during cell cycle re-entry remain elusive. Using a powerful combination
of Western blotting, SILAC-mass spec, ChIP-seq, and RNA-seq, we set out to investigate how
nutritional status and metabolic state impact the genome-wide pattern of individual histone
modifications, and their turnover.

Figure 1.8. Chromatin-mediated transcriptional control by intermediary metabolism
During feeding or under high glucose conditions, acetyl-CoA from glycolysis is exported to the nuclear–
cytosolic compartment. In the nucleus, increased acetyl-CoA – rate-limiting to the catalytic activity of HAT
enzymes – is allowing for increased histone acetylation. In that way, rising acetyl-CoA creates a permissive
state for creating a permissive state for transcription of genes involved in glucose uptake and glycolysis
constituting a feed-forward loop acetyl-CoA transmits the signal of increased nutrient supply. (adapted from
Gut and Verdin, 2013)19

ChIP-seq is a valuable technology enabling the study of a broad range of chromatin
phenomena on a genome-wide scale, and provides position- and gene-specific mapping.
Nonetheless, ChIP-seq does not capture the temporal dynamics of histone modification turnover.
SILAC-mass spec, in contrast, is a formidable tool that permits detection and quantification of
relative differential changes in histone modifications over time. We successfully applied this
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technology to interrogate the reciprocal relationship between glucose uptake, glycolytic
metabolism, and regulated histone acetylation. In combination, ChIP-seq and SILAC-mass spec
allowed comprehensive profiling of chromatin during changing nutritional and metabolic
environments. Used together, these technologies yielded superior insight that each approach on
its own could not provide.
Our findings from SILAC and ChIP-seq provided the first unequivocal evidence that
nutrients induce an immediate histone acetylation response at growth-related genes, driven by
external glucose. Notably, whereas solid evidence showed that specific histone acetylation can
translate metabolic signals into alterations in chromatin structure and transcription, the
relationship between metabolic state and the uniquely multifaceted methylation of histones
remained virtually unexplored. We thus set out to investigate whether metabolism modulates
histone methylation to control gene expression in the transition from quiescence to cell
proliferation, akin to histone acetylation.
Histone methylation is a far more complex process than acetylation. Histone
methyltransferase (HMT) and demethylase (HDM) enzymes regulate mono-, di-, and
trimethylation states of multiple histone lysine residues that have diverse functions in
transcriptional control40. HMT enzymes have striking target specificity – usually modifying one
single lysine on a single histone – and their output can be either activation or repression of
transcription. To methylate histones, methyltransferases are dependent on the metabolic
intermediate and sole methyl group donor S-adenosyl methionine (SAM)41. Histone methylation
could in theory reprogram gene expression in function of the metabolic milieu, based on its
dependence on metabolic SAM, whose availability is governed by the intracellular energy
content. The SAM precursor methionine is an essential amino acid that mammal cells cannot
synthesize de novo42. For that reason, SILAC-based studies are an excellent approach to probe
the relationship between cellular metabolism and epigenetic control of histone methylation. Thus,
when heavy stable isotope form of methionine, L-Methionine-methyl-13C, D3, is used in the cell
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culture medium, heavy-methyl groups will be introduced by methyltransferases into lysine and
arginine residues on histone proteins. This labeling technology coupled with quantitative mass
spectrometry technology facilitates the study of complex site-specific methylation dynamics on
histone proteins26,43.
Interestingly, our application of both SILAC and ChIP-seq technology demonstrated that
histone methylation – in contrast to highly dynamic histone acetylation – remains exceptionally
stable and uncoupled from rapid metabolic and transcriptional reprogramming as yeast cells exit
quiescence. Instead, our studies revealed that the methylation landscape is extensively
restructured genome-wide only at a later time, in conjunction with genome replication and
ensuing cell division27. Notably, as global histone methylation levels do not change immediately in
the exit from quiescence, these dynamic changes in genome-wide methylation patterns would
have remained obscured when analyzed by Western blot alone. Thus, the combination of SILACmass spec with ChIP-seq provided distinct interpretations of the dynamics of histone acetylation
compared to histone methylation during re-entry into the cell cycle.

BEYOND THE ABOVE: EPIGENETIC MECHANISMS IN COGNITION
The ability to store information over long periods of time lies at the heart of cellular
identity. Cellular memory – encoded in the epigenetic signatures that govern gene expression –
ensures that cells do not drift when moving along elaborate pathways in cellular development and
differentiation. In analogy, our own mental identity relates to memories that make sure we
remember who we are when navigating the incredibly complex world that surrounds us. The
elemental question of how the exceptional variety of stimuli submitted to neurons are converted
into higher order brain functions such as memory storage, however, continues to perplex in the
field of neuroscience. Today, deepening our understanding of the molecular machinery that
underlies long-term memory consolidation and storage is a primary goal in contemporary studies
of cognition.
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It is fascinating that one potential molecular mechanism by which behavioral memories
may be fixed and persist in a structure as dynamic as our brain may ultimately be of epigenetic
nature44–48. Learning-induced epigenetic modifications at the cellular level could serve to support
memory in the adult brain, through stable alterations in the chromatin structure of neurons44.
Changes in chromatin occur during the earliest stages of neuronal development, and epigenetic
mechanisms play critical roles in neurogenesis, the specification of neuronal fates, and the
development of neural circuitry in the brain. Without a doubt, such epigenetics-related molecular
mechanisms are functionally active in terminally differentiated, non-dividing neurons of the adult
brain. In fact, current research strongly supports the prevailing hypothesis that neuronal plasticity
involves epigenetic regulation. Recent studies highlight alterations in chromatin structure, via
histone modifications, as critically important for the long-term stability of plastic changes at the
circuit and behavioral levels49–52. Epigenetic modifications have now been implicated in neuronal
plasticity, neurodegeneration, and psychiatric conditions, such as drug addiction53–56. In fact,
there are several types of epigenetic modifications that have been associated with cognitive
functions, including DNA methylation, RNAi, and post-translational modification of histone
proteins by acetylation, methylation, phosphorylation45,48,56,57. Yet histone acetylation in particular
has spurred considerable interest, and is most robustly associated with promoting memory
formation.
As early as 1979, that is, nearly two decades before the first nuclear HAT was
discovered58, it was found that the acetylation state of histones is altered when rats undergo
memory consolidation59. More recent evidence confirmed these findings, showing that specific
forms of associative learning – contextual fear conditioning and latent inhibition – correlate with
increased histone acetylation50. Following contextual fear conditioning, acetylation of H3K14 was
significantly increased in the hippocampus proper, the cornus ammonis (CA1; Fig. 1.9), whereas
acetylation of H4 was unchanged. Conversely, H4 acetylation was selectively increased after
latent inhibition training. While Schmitt and Matthies used C14-labeled acetate to study histone
acetylation59, these later studies used immunoblotting to detect bulk levels of histone
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modifications. The mechanistic insight from such early observations is limited since they do not
allow to identification of the genomic regions in which altered histone acetylation takes place.
However, importantly, these early results not only highlighted that histone acetylation
accompanies memory consolidation, but show that different learning paradigms elicit distinct
epigenetic signatures in the brain. Many follow-up studies have corroborated the implied link
between histone hyper-acetylation and memory formation for different memory types and phases,
such as reconsolidation and extinction49,60–65.

Figure 1.9. Schematic of hippocampal anatomy and contribution to behavior.
Drawing of the hippocampal formation in mouse, located in the medial temporal lobe. The frontal cross-section
depicts the histological subdivision of the hippocampus by Nissl stain in the frontal cross-section, and
delineates the CA1, CA2, and CA3 regions together with the dentate gyrus (DG). The dorsal and ventral
hippocampus have distinct contributions to behaviour. Subregion specific, cytotoxic lesions have fractionated
the hippocampus in terms of their behavioural effects. The dorsal hippocampus subserves the spatial memory
functions of the hippocampus (for example, in the water maze and radial maze), whereas the ventral
hippocampus underlies the anxiolytic effects of hippocampal lesion. (adapted from Bannerman et al., 2014)65

For instance, newer studies using chromatin immunoprecipitation have revealed that
memory-induced histone acetylation is specific to certain genes. These include genes that are
important for learning and memory, such as the immediate-early genes Erg1, Creb and Bdnf,
which showed an increase in expression following contextual fear learning, concomitant with the
increase in histone acetylation52,64,65. Relevantly, phosphorylation of the transcription factor
cAMP-response element-binding protein (CREB) is critical during these time windows for longterm memory. These windows of CREB phosphorylation coincide with sensitive periods during

16

which inhibition of transcription impairs memory storage66. Notably, recent evidence showed that
CREB phosphorylation alone is not sufficient to drive such gene expression. Instead, it is the
interaction between phosphorylated CREB and the histone acetyltransferase CREB-binding
protein (CBP/KAT3A) that is critical for memory formation, and that is associated with increased
histone acetylation levels at CREB target genes (Fig. 1.10).

Figure 1.10. Functional mechanisms of transcriptional activation by CBP/p300
CBP/p300 promotes transcriptional activity by recruiting transcriptional machinery to the promoter, and by
modifying chromatin structure to facilitate transcription. (a) CBP/p300 functions as a “bridge”, linking the DNAbound transcription factors (activators) to basal transcription machinery through direct interactions with TFIID,
TFIIB, and RNA Pol II, thus promoting pre-initiation complex (PIC) assembly. (b) CBP/p300 acetylates
histones through its HAT domain, resulting in chromatin remodeling and relaxation of chromatin structure to
enable transcription. CBP/p300 also recruits the coactivators PCAF and GCN5. (from Wang et al, 2013)67

The functional relevance of histone acetylation for memory formation was first
demonstrated via genetic mouse models in which the activity of CBP was reduced51,52,68. These
mutant mice displayed impaired memory consolidation, a finding that has been reproduced in
various mouse models in which CBP activity was altered52,69,70. Additionally, it was found that
pharmacological inhibition of HDACs in the hippocampus enhances the consolidation of
associative memories in rodents50,71–74, requiring the interaction of CREB and CBP. Surprisingly,
data in which ChIP-qPCR for specific histone-modifications was analyzed during memory
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formation are sparse. The current state of the art method to study chromatin marks across the
entire genome is ChIP followed by next-generation sequencing. A recent study performed a
genome-wide analysis of H4K5ac via ChIP-sequencing and found that H4K5ac correlates with
learning-induced gene expression75. In general, increments in histone acetylation have
consistently been shown to favor learning and memory. In contrast, an inability to acetylate has
been causally implicated in cognitive impairments in neurodevelopmental disorders,
neurodegeneration and ageing44,46,68,76–78.

Figure 1.11. Synthesis of acetyl-CoA in yeast and mammalian cells
In mammalian cells, mitochondrial acetyl-CoA is produced from pyruvate by the pyruvate dehydrogenase
complex or by the β-oxidation of fatty acids, and then feeds into the tricarboxylic acid (TCA) cycle. Citrate can
be exported from mitochondria into the cytoplasm, where it freely diffuses into and out of the nucleus. The
extra-mitochondrial pool of acetyl-CoA, which is used for protein acetylation or for lipogenesis, is synthesized
from citrate by ATP citrate lyase (ACL) or from acetate by acetyl-CoA synthetase 2 (ACSS2). Because these
enzymes use different substrates for generating acetyl-CoA, the relative importance of ACL and ACSS2 in
non-mitochondrial acetylation may depend on differences in carbon source utilization. Similar to mammalian
cells, yeast generate acetyl-CoA via pyruvate metabolism in mitochondria. However, in yeast,
nucleocytoplasmic acetyl-CoA is exclusively provided by the catalytic activity of acetyl-CoA synthetase
enzymes. Although the enzymes and mechanisms of acetyl-CoA generation are different between mammalian
cells and yeast, in both cases acetyl-CoA is produced through more than one route and in different subcellular
compartments. (adapted from Wellen and Thompson, 2012)16
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On the whole, there is a substantial body of data demonstrating that enzymes regulating
histone acetylation have critical roles in memory function. In view of the novel paradigm of
chromatin-mediated transcriptional control by cellular metabolism, we were interested whether
such mechanism may operate in the adult nervous system – particularly in the context of
dynamically increased histone acetylation regulating memory formation. To catalyze the histone
acetylation reaction, HAT enzymes depend on the central metabolite acetyl-CoA as the sole
acetyl group donor. In mammals, nuclear acetyl-CoA that contributes to histone acetylation is
principally produced by two enzymes: ATP citrate lyase (ACL) utilizing citrate to generate acetylCoA79, and the acetate-dependent acetyl-CoA synthetase ACSS280–82. Intriguingly, ACSS2 has
been shown to localize primarily to the nucleus throughout development, and its expression was
found to be maintained at high levels in the adult nervous system 83. In contrast, ACL
predominantly locates to the cytoplasm, and is highly expressed in tissues with substantial levels
of lipogenesis, including the developing brain84,85.
Acetyl-CoA is the principle building block for de novo lipogenesis, a process that is
particularly important in the developing brain, mostly for myelination. Both ACL and ACSS2 are
believed to contribute acetyl-CoA to this process in development. Interestingly, ACL expression
was found to be lower in the adult brain, reflecting reduced levels of de novo lipogenesis.
However, ACL expression persists at high levels in cholinergic neurons of the brain stem and
spinal cord83, suggesting a role in acetylcholine synthesis, which is indeed stimulated by
supplementation of the ACL substrate citrate86. Collectively, these findings suggest that the
primary source for acetyl-CoA functioning in neuronal histone acetylation is catalytic ACSS2. This
hypothesis is supported by our findings in the yeast S. cerevisiae. In yeast, the homolog of the
evolutionary highly conserved ACSS2 is the acetyl-CoA synthetase Acs2p87. Notably, in contrast
to mammalian cells, yeast Acs2p is essential and the exclusive enzymatic source of
nucleocytoplasmic acetyl-CoA during growth on glucose88. In fact, using SILAC and ChIP-seq, we
showed unequivocally that the Acs2p-dependent histone acetylation response to nutrient feeding
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is driven by metabolized external glucose. All the more, earlier studies showed that virtually all
Acs2p is present in the nucleus, localizing into distinct nuclear clusters including the nucleolus88.
These data caused us to hypothesize that chromatin-localized production of acetyl-CoA
by ACSS2 regulates histone acetylation and gene transcription in post-mitotic neurons.
Specifically, we hypothesized that ACSS2 is required for dynamic histone acetylation and gene
expression involved in long-term memory formation. Our data show that ACSS2 is a critical and
direct regulator of histone acetylation in neurons and of long-term mammalian memory. Our
findings from comprehensive ChIP-seq analyses in neuronal cell culture indicate that ACSS2
functions as a chromatin-bound co-activator, locally promoting histone acetylation for transcription
of neuron-specific genes. Remarkably, in vivo attenuation of hippocampal ACSS2 expression in
adult mice impairs long-term spatial memory, associated with defective induction of key neuronal
genes involved in memory. These results reveal a unique connection between cellular
metabolism and neural plasticity, providing new mechanistic insight that may lead to novel
pharmacological strategies in treating neurodegenerative and neuropsychiatric disease.
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CHAPTER 2
HISTONE METHYLATION HAS DYNAMICS DISTINCT FROM THOSE OF HISTONE
ACETYLATION IN CELL CYCLE REENTRY FROM QUIESCENCE
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ABSTRACT

Cell growth is attuned to nutrient availability to sustain homeostatic biosynthetic
processes. In unfavorable environments, cells enter a non-proliferative state termed quiescence,
but rapidly return to the cell cycle once conditions support energetic needs. Changing cellular
metabolite pools are proposed to directly alter the epigenome via histone acetylation. Here we
studied the relationship between histone modification dynamics and the dramatic transcriptional
changes that occur during nutrient‐induced cell cycle re-entry from quiescence in the yeast S.
cerevisiae. SILAC‐based mass spectrometry showed that histone methylation – in contrast to
histone acetylation – is surprisingly static during quiescence exit. ChIP‐seq revealed genome‐
wide shifts in histone acetylation at growth and stress genes as cells exit quiescence and
transcription dramatically changes. Strikingly, however, the patterns of histone methylation
remain intact. We conclude that the functions of histone methylation and acetylation are
remarkably distinct during quiescence exit: acetylation rapidly responds to metabolic state while
methylation is independent. Thus, the initial burst of growth gene reactivation emerging from
quiescence involves dramatic increases of histone acetylation, but not of histone methylation.
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INTRODUCTION
Cells constantly sense and integrate environmental cues to control proliferative growth,
but the underlying molecular mechanisms remain unclear. Eukaryotic cells, including adult stem
cells, typically exist in a state of growth arrest – quiescence – that is distinguished by two
principal qualities: quiescent cells both safeguard cell identity and retain the ability to resume
proliferation once external cues become favorable 35,89,90. Remarkably little is known about the
molecular processes that mediate quiescence exit and the transition to proliferative growth, which
requires massive changes in cell metabolism and reprogramming of global gene expression

91–93.

Recent evidence suggests that the metabolic state is a principle regulator of quiescence
establishment and exit via epigenetic changes that alter gene expression

15,94,95.

A clear example

is that nutrient-induced increases in acetyl coenzyme A (acetyl-CoA) pools promote chromatin
acetylation and growth gene transcription

38,39.

Rhythmic fluctuations of acetyl-CoA levels are

characteristic of the metabolic cycle that budding yeast cells enter during growth in nutrientlimiting conditions. In such a milieu, recurrent bursts of acetyl-CoA production by the enzyme
acetyl-CoA synthase Acs2p have been linked to increased histone acetylation and growth gene
expression, indicating a functional connection between metabolic state and gene transcription via
chromatin acetylation 38. Indeed, studies in both the yeast S. cerevisiae and activated
lymphocytes indicate that glucose-induced histone acetylation is a critical and highly conserved
driver of quiescence exit 39,96,97. In mammalian cells, acetyl-CoA synthesis by ATP-citrate lyase
(ACL) has been shown to link nutrient-dependent histone acetylation and cellular growth. These
findings suggest a model of transcriptional control via conserved connections between metabolic
and epigenetic states 18,37,98.
Even though metabolic activities are coupled to histone acetylation and growth gene
transcription, it is uncertain whether cellular metabolites also influence histone methylation to
dynamically regulate transcription. Notably, histone methylation is a far more complex process
than acetylation. Histone methyltransferase (HMT) and demethylase (HDM) enzymes regulate
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mono-, di-, and trimethylation states of multiple histone lysine residues that have diverse
functions in transcriptional control 40. Histone methylation is dependent on the central metabolite
S-Adenosyl-Methionine (SAM). Based on this, it has been speculated that intracellular SAM
concentrations may modulate chromatin structure in response to the metabolic milieu

99.

The

high-energy methyl donor SAM is generated from methionine by methionine adenosyltransferase
(MAT) enzymes in an ATP-consuming reaction, and its chromatin-localized synthesis
concentration is believed to fine-tune histone methylation 100. Recent evidence suggests that
threonine metabolism may selectively influence di- and trimethylation of histone H3 lysine 4
(H3K4me3) specifically in mouse embryonic stem cells (mESCs) by supplying acetyl-CoA for
SAM synthesis during mESC colony growth 101.
Overall, it remains unknown whether histone methylation is a broad energy sensing
modification that adapts transcription relative to the metabolic state, akin to histone acetylation.
The dynamics of histone methylation have not been examined in cells transitioning from minimal
to high metabolic activity, and methods to reliably determine residue-specific methylation
dynamics using mass spectrometry have been only recently developed

26.

To explore the role of

histone methylation as a putative energy sensor in the context of massive metabolic and
transcriptional reprogramming, we investigated the temporal dynamics of global histone
methylation during cell cycle re-entry of quiescent budding yeast S. cerevisiae. Our results show
that histone methylation operates in stark contrast to highly dynamic glucose-induced histone
acetylation, with methylation levels remaining highly stable during quiescence exit.

24

RESULTS
Histone methylation does not change globally during cell cycle re-entry

Nutrient abundance induces quiescence exit and stimulates vast changes in cellular
metabolism. Presently, the metabolic state is under intense investigation as a principle regulator
of both chromatin and gene expression 94. Indeed, previous observations show that global histone
acetylation is dramatically altered during nutrient starvation and re-feeding 39. During nutrientinduced quiescence exit, glycolytic metabolism has been found to be the central driver of bursts
of histone acetylation 39. We investigated the unexplored changes in histone methylation that may
occur upon quiescence establishment and during cell cycle re-entry.
Quiescence establishment in yeast is a gradual process involving the stepwise
acquisition of various quiescence traits culminating in the final cessation of proliferation. In order
to obtain a homogenous population of quiescent cells and eliminate contamination of slowly
cycling subpopulations, we achieved quiescence, as previously described

102,

by transferring cells

from carbon-exhausted media into water to ensure complete nutrient starvation prior to the
induction of quiescence exit. To investigate and compare chromatin modification dynamics over
the course of this process, we examined proliferating cells (LOG), cells in the quiescent state (Q),
early exiting cells before DNA replication (E 30 min), and late exiting cells after DNA replication
commences (E 240 min) (Fig. 2.1A). We measured changes in global histone methylation
abundance by western blot and Stable Isotope Labeling using Amino acids in Cell culture
(SILAC)-mass spectrometry (hereafter referred to as SILAC). We then used chromatin
immunoprecipitation followed by massive parallel sequencing (ChIP-seq) to examine changes in
local genic modification patterns. In each of these experimental approaches we compared
histone methylation to histone acetylation, which is known to undergo dramatic fluctuations in cell
cycle exit and re-entry.
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Figure 2.1. Nutrient availability stimulates histone acetylation and dramatic change in gene
expression, but does not alter global histone methylation levels.
(A) Schematic of yeast culturing and quiescence exit protocol. Yeast are grown in rich medium (LOG) until
carbon exhaustion, and are then transferred to water to ensure a completely starved, homogeneous quiescent
cell population (Q) prior to nutrient-induced quiescence exit on day 8. An arrow indicates nutrient feeding and
subsequence sampling times 30 minutes and 240 minutes after nutrient feeding (E30 and E240, respectively).
(B) mRNA-sequencing data show that nutrient feeding (indicated by an arrowhead) induces vast
transcriptional reprogramming in the transition from quiescence to cellular growth. Following nutrient
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replenishment, 475 growth genes are drastically up-regulated (indicated in orange), whereas a core set of 463
stress genes are rapidly down-regulated (blue). Data are clustered by time points into columns, and rows that
represent genes, ranked by FPKM values normalized to quiescence sample FPKM and log2-transformed. (C)
GO-term enrichment analysis shows that growth genes are involved in processes critical to growth. Stress
genes cluster in classic stress response categories. (D, E) western blot analysis of lysates from yeast over the
course of quiescence exit reveals that total levels of histone acetylation are diminished in quiescent cells and
rapidly increase following nutrient replenishment. In contrast, global histone methylation levels remain stable
throughout quiescence establishment and do not increase during quiescence exit.

First, to confirm that quiescence exit results in expected dramatic gene expression
changes in our experiments, we performed RNA sequencing. As previously noted by gene
expression microarray analysis

91–93,

we observed that during the exit from quiescence, nutrients

trigger a massive transcriptional response that involves one third of yeast genes. The rapid
transformation of the global gene expression program produces an mRNA transcriptome in the
early exit (E30) that closely resembles the transcriptional profile of cycling cells (LOG), as shown
in a Pearson correlation matrix (Fig. 2.1B). Thus, the massive changes in transcription do not
require replication. Following nutrient feeding, a core set of roughly 500 growth genes is
immediately and dramatically up-regulated (Fig. 2.1C, top panel), whereas another group of
nearly 500 stress genes is promptly down-regulated (Fig 1C, bottom panel). As expected, Gene
Ontology (GO) enrichment analyses indicate that nutrient-induced growth genes are involved in
processes critically important for growth, including ribosome biogenesis, rRNA processing and
translational regulation (Fig. 2.1D). In contrast, genes that are actively transcribed in quiescent
cells and become rapidly down-regulated after nutrient-feeding are highly overrepresented in
classic stress response categories, such as oxidation reduction and response to heat (Fig. 2.1D).
The induction of growth genes has been shown to correlate with glucose-dependent
increases in histone acetylation 38,39. We confirmed by western blot analysis that transcriptionally
relevant histone acetylation levels drop dramatically during quiescence and then robustly and
rapidly increase after nutrient refeeding as the cells exit quiescence (Fig. 2.1E, H4K5ac and

27

H4K8ac; Fig. 2.1F, H3K9ac). Strikingly, western blot analysis revealed that for all of the abundant
methylation sites relevant to transcription (K4, K36 and K79), there was no global change during
nutrient starvation and replenishment (Fig. 2.1E, F). Thus, in stark contrast to histone acetylation
that is connected to transcription, global histone methylation levels remain constant in nutrientstressed quiescent cells and do not increase during nutrient-induced cell cycle re-entry.
Histone methylation dynamics are distinct from histone acetylation during exit

While western blot analysis measures the total relative abundance of specific histone
modifications, this technique is unable to measure either turnover dynamics or changes in
genome-wide distribution of those modifications. Although the kinetics have not been previously
reported in exiting cells, it has been speculated that turnover dynamics of various histone
modifications correspond to cellular metabolism

18,99.

To investigate methylation dynamics, we

performed SILAC in quiescent and quiescence-exiting cells.
SILAC is a popular quantitative proteomics approach that relies on the endogenous translational
machinery of living cells to incorporate tagged chemical analogs of molecular building blocks into
chromatin23,24. In the classical SILAC experiment, two cell populations are compared 24. These
populations are grown in different media containing distinct forms of amino acids that are either of
natural isotopic abundance or heavy labeled stable isotopes. Incorporation of these light and
heavy amino acids into de novo synthesized proteins creates proteomes that can be discerned by
their specific mass differences. Mass spectrometry is used to measure the relative abundance of
light and heavy peptides in pooled samples, which allows for the detection and quantification of
differential changes in protein expression. In order to study temporal turnover dynamics of
chromatin modifications, we adapted this classic SILAC approach to analyze site-specific
dynamics of histone acetylation and methylation25. Our labeling approach provides an effective
marker to distinguish pre-existing from newly catalyzed chromatin modifications, and permits the
monitoring of time for dynamic turnover, when coupled with advanced quantitative liquid
chromatography-mass spec technology26,27.
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To track and quantify histone protein turnover, as well as newly acetylated and
methylated histones, we cultured cells in media with isotopically heavy lysine ( 15N2-13C6-lysine),
glucose (13C6-glucose), or methionine (13CD3-methionine), respectively, prepared nuclei, and
isolated histones (Fig. 2.2A, left panels). While the stable heavy isotopes do not perturb the
system

26,103,

label incorporation rate into histone modification pools can be monitored by tandem

mass spectrometry analysis. Specific shifts in the mass-to-charge (m/z) ratio are used to
distinguish unlabeled from labeled histone peptides and to reveal modification turnover rates
when measured with respect to time of continuous isotopic labeling (Fig. 2.2A, right panels). In
contrast to a shift in m/z, the incorporation of the heavy isotopes generally does not induce a
significant shift in retention time and thus histone peptides with light, heavy, or a combination of
both isotopes generally co-elute by reversed phase liquid chromatography. By measuring the
metabolic rate of labeled isotope incorporation into histone modifications, we determined the
residue-specific dynamics of acetylation and methylation in the context of major transcriptional
reprogramming during quiescence exit.
To establish conditions and explore histone methylation by SILAC, we first examined
turnover of both histone protein and histone methylation in proliferating cells. First, to track
turnover of histone proteins in cycling cells, we performed SILAC using heavy lysine (Fig. 2.2B).
Following the transfer of proliferating cells to heavy media, any histones that have incorporated
isotopically heavy 13C6-15N2 lysines can be distinguished as ‘newly’ synthesized histone proteins.
We found that the half-max labeling time (t1/2) of histone proteins corresponds to approximately
one budding yeast cell cycle of 130 minutes, confirming by SILAC that doubling of the histone
protein pool occurs once with every cell division (Fig. 2.2B).
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Figure 2.2. SILAC-mass spectrometry analysis of histone protein and methylation dynamics in
proliferating cells.
(A) Methodology of SILAC-based quantitative mass spec. Cells are cultured in media containing
labeled heavy isotopes (e.g. 13CD3 methionine to track methylation). Isotope incorporation (shown in orange)
into histone peptides or modification pools is monitored by tandem mass spec analysis. Specific shifts in the
mass to charge (m/z) ratio are used to distinguish unlabeled from labeled histone peptides or modifications
and reveal turnover dynamics when measured over time (e.g. 4 Da shift per methyl group). (B) SILAC with Llysine-13C6 in proliferating cells shows relative distributions and half-max labeling time of newly synthesized
H3, H4, and H2A peptides, confirming doubling of the histone pool with every cell division (~130 minutes). (C)
Methyl-SILAC with heavy

13CD -methionine
3

in proliferating cells shows rapid incorporation of

13CD 3

methionine into histone methylation of H3K36 (y-axis represents total methylation labeling, e.g. 0.9 denotes
90% labeling) (D) SILAC mass spec reveals the percentage of unmodified and mono-, di-, and tri-methylated
histone H3 at residues K79, K36, and K4 in proliferating cells.
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Next, to examine residue-specific methylation dynamics in proliferating cells, we utilized
heavy methionine SILAC. This method involves mass spectrometry detection of in vivo
incorporation of labeled S-adenosyl methionine (SAM), originating from metabolized exogenous
13CD

3-methionine

into endogenous methylation substrates. The SAM precursor methionine is an

essential amino acid that mammal cells cannot synthesize de novo. Thus, when heavy stable
isotope form of methionine, 13CD3-methionine, is used in the cell culture medium, heavy-methyl
groups will be introduced by methyltransferases into lysine and arginine residues on histone
proteins. Indeed, heavy methionine was rapidly metabolized to SAM, and we detected histone
methylation labeling within minutes of transfer to heavy media (Fig. 2.2C). We detected ratios of
mono-, di-, and tri-methylated histone H3 that are consistent with their abundance and prevalent
functions at promoters (K4), over partial gene bodies (K36), and over entire gene bodies (K79)
(Fig. 2.2D).
Methylated peptide species are commonly denoted for each methylation residue with
X:Y, where X is the number of total methyl groups, and Y is the number of labeled methyl groups.
For instance, H3K36me1:0 refers to unlabeled monomethylated H3K36, and H3K36me1:1 refers
to labeled monomethylated H3K36. In order to reveal the distribution of differently labeled species
within a methylation state, their relative abundance is calculated after all methylation
intermediates for a specific methylation state of a particular residue have been determined. For
instance, the abundance of H3K36me1:0 would be determined with respect to H3K36me1:0 and
me1:1. This calculation is based on the logic that growth conditions should not change with
12CH3- or 13CD3-methionine, and that the total abundance of each methylated species does not
change20. The relative distribution can then be used to quantify half-maximal times of the
formation of labeled peptides (t½). The half-maximal time provides a measure of how quickly a
particular species is formed, and thus is predictive of the overall rate of methylation for that
species.
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Having established SILAC in proliferating cells to study histone modification dynamics,
we then applied this method to quiescent cells that were induced to re-enter the cell cycle by
nutrient feeding. First, as a control for the method, we examined glucose-dependent histone
acetylation in quiescence exit by utilizing heavy glucose SILAC. Similar to Methyl-SILAC, this
method relies on mass spectrometry to detect and quantify heavy carbon labeling of histone
acetylation at several time points, resulting from the glycolytic breakdown of heavy [13C6]glucose in the labeling media. By mass spectrometry, we detected a burst of histone acetylation
that occurs immediately after nutrient replenishment, resulting from the glycolytic breakdown of
heavy-labeled 13C6-glucose from fresh media (Fig. 2.3A). Specifically, new histone H3K9/K14
acetylation takes place within minutes (Fig. 2.3A, red), thus supporting the turnover dynamics of
previously reported Western blot analyses that show rapid increases in histone acetylation (Fig.
2.1E, F) 39.
We found that labeling of N-terminal histone H2A acetylation occurs only after several
hours into the exit (Fig. 2.3A, blue). N-terminal acetylation is a prevalent and highly conserved
eukaryotic protein modification that is mediated co-translationally; hence our data indicate that
histone protein synthesis commences late in the exit and is concurrent with DNA replication.
Consistent with this observation, label incorporation into the histone protein pool via alanine
residues also occurs very late upon cell cycle return (Fig. 2.3A, grey). These data demonstrate
the absence of a slowly cycling subpopulation of cells and indicate homogeneity of the quiescent
population.
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Figure 2.3. Histone methylation, unlike acetylation, remains static during quiescence exit.
(A)

13C -glucose-SILAC
6

shows an immediate nutrient-induced increase in labeling of histone H3 acetylation

(H3K9/K14ac1*). N-terminal histone H2A acetylation is mediated co-translationally and becomes labeled only
late in exit, concurrently with alanine labeling of newly synthesized histone proteins. (B) Methyl-SILAC during
quiescence exit shows that all H3 K4, K36, and K79 methylation states remain remarkably static during
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nutrient-induced cell cycle re-entry, and new methylation occurs only late in exit concomitantly with histone
protein synthesis. (C) Mass spectrometry confirms rapid labeling of cellular SAM pools by

13CD -methionine
3

in proliferating cells (log0’ and log30’) and upon nutrient replenishment in quiescent cells when histone
methylation remains static. (D) Levels of methyl-donor SAM were assessed. Cellular SAM levels are slightly
lowered in quiescence, but rise during early quiescence exit to levels characteristic of cycling cells. (E) Mass
spectrometry shows that the overall levels of the corresponding methylated H3 peptides remain constant.

We then examined histone methylation dynamics with methyl-SILAC as the cells reentered the cell cycle. Intriguingly, histone methylation remains remarkably static throughout
quiescence exit. This trend was true of all H3K4, K36, and K79 methylation states, representing
all of the abundant transcriptionally-linked histone methylation sites in yeast (Fig. 2.3B). Indeed,
de novo histone methylation occurs only late during cell cycle re-entry, well after the burst of
histone acetylation (compare Fig. 2.3B to 3A). We again confirmed that histone proteins are
synthesized late in the exit, as assessed above by heavy glucose SILAC (Fig. 2.3A, grey), and
here by heavy lysine SILAC (data not shown). Thus, new histone methylation occurs
coincidentally with histone protein synthesis late in the exit when cells resumed replication.
We wanted to test a trivial explanation for the lack of change of methylation compared to
acetylation in the early exit. It is possible that saturation of in vivo SAM pools with exogenous
13CD

3-methionine

is slower than saturation of in vivo acetyl-CoA pools with exogenous 13C6-

glucose in yeast cells undergoing quiescence exit. This would result in an apparently slower rate
of pulse labeling of methyl groups compared to acetyl groups. To address this, we tested by mass
spectrometry of SAM whether 13CD3-methionine was rapidly taken up and incorporated into SAM
pools during re-feeding. We found that heavy labeling of SAM occurs early in the exit by 30
minutes (E30’ in Fig 3C) and is comparable to labeling of SAM in cycling cells during log growth
(log30’ in Fig. 2.3C). We further confirmed that cellular SAM levels in cells exiting quiescence are
similar to proliferating cells (Fig. 2.3D). While the SAM concentration is slightly lower in quiescent
cells, cellular SAM pools readily rise during the early exit to levels typical for cycling cells (Fig.
2.3D), at a time when massive transcriptional changes occur in the absence of novel histone
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methylation as shown by heavy-methyl SILAC (Fig. 2.3B). In addition to the absence of dynamic
increase in histone methylation upon quiescent exit, we also noted by mass spectrometry that
overall levels of the corresponding methylated peptides are constant (Fig. 2.3E), validating our
findings by western blot analysis (Fig. 2.1E, F). Taken together, the SILAC analysis shows that
histone methylation is surprisingly static during quiescence exit and is wholly different from the
dramatic induction of histone acetylation during massive changes in gene expression. New
histone methylation only appears late, concurrent with replication and concomitant histone protein
synthesis.
Histone methylation is redistributed genome-wide during quiescence and exit

We were surprised that histone methylation remains static in the backdrop of massive metabolic
and transcriptional change. While genome-wide histone acetylation patterns have been
investigated in nutrient-stressed cells 39, the histone methylation status of growth and stress
genes during quiescence and exit is unknown. We investigated the genome-wide distribution of
histone modifications during quiescence and exit, focusing on two core groups of genes that have
been previously described by microarray analysis as prominently transcribed during growth and
during nutrient stress 92,93,104, which we confirmed by our RNA-analysis (Fig. 2.1C, D).
We performed ChIP-seq in the same time-course to examine and compare histone
acetylation and histone methylation. Histone acetylation at growth genes becomes greatly
diminished in quiescence (Fig. 2.4A left). When these growth genes are induced upon nutrient
replenishment, H3K9ac (Fig. 2.4A, left) and H4K12ac (Fig. 2.4B, left) rapidly increases at these
loci. In contrast, H3K9ac and H4K12ac in quiescent cells is enriched at stress genes that are
induced upon nutrient starvation, and then diminishes in E30, E240, and LOG (Fig. 2.4A and 2.4B
right). Thus, our findings confirm observations previously made in similar conditions of nutrient
limitation and environmental stressors

38.
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Figure 2.4. Histone methylation is redistributed as proliferating cells enter quiescence, but
remains static in early exit from quiescence.
Average ChIP-seq enrichment of H3K9ac (A), H3K36me3 (B), and H3K4me3 (C) over scaled bodies (from
the transcriptional start site “TSS” to the transcriptional termination site “TTS”; normalized to H3 ChIP signal)
of all growth and stress genes characterized in Fig. 2.1 reveals differences between histone acetylation and
methylation levels at these two distinct gene groups during quiescence establishment and exit.
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We then analyzed genome-wide enrichment patterns of H3K4me3 and H3K36me3, which
are associated with active gene expression. While overall global methylation levels remain stable,
as shown by western blot analysis and mass spectrometry (Fig. 2.1F and 2.3E), we detect
genome‐wide shifts in the methylation status of growth and stress genes when we compare cells
that have gone through the long process of establishing the quiescent state: note that the
dotted/red lines (LOG and E240) are distinct from the blue/orange (Q and E30) (Fig. 2.4C and
2.4D). Specifically, histone methylation at growth genes is decreased during quiescence (Fig.
2.4C and 2.4D, left), whereas methylation at stress genes is increased (Fig. 2.4C and 2.4D, right).
Strikingly, this new methylation pattern established during quiescence remains largely intact
through early exit (i.e. Q and E30 lines are very similar) despite the enormous changes in
transcription and histone acetylation that occur after re-feeding (Fig. 2.1). We do note that, at
stress genes, H3K4me3 drops partially at E30, which might be related to the down-regulation of
these genes as the cells leave quiescence. Importantly, new histone methylation at growth genes
occurs only during the late exit (E 240 min) when the cell cycle is fully engaged (Fig. 2.4C and
2.4D, left). To confirm these genome-wide methylation data, we performed ChIP qRT-PCR in
time-course for H3K4me3 and H3K36me3 for individual growth and stress genes (Fig. 2.5).
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Figure 2.5. Histone methylation at individual stress and growth genes remains stable upon
nutrient replenishment.
ChIP-qPCR was performed in time-course to reveal H3K4me3 and H3K36me3 at a representative stress
gene, PCK1 (A), and two representative growth genes, RPL33B and SHM2 (B), confirming that methylation
levels remain unchanged during the early exit. Data are shown as ratios of modification to total histone H3.
ChIP-qPCR data are the average of three biological replicates, and error bars represent standard deviation
from the mean.
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The clear quantitative contrast between genome-wide acetylation and methylation is
most easily visualized by box plot analysis (Fig. 2.6). H3K9ac drops at stress genes between Q
and E30 and increases at growth genes between Q and E30. In contrast, H3K4me3 and K36me3
remain constant at both stress and growth genes between Q and E30. Importantly, these ChIPseq findings for histone methylation agree with our methyl-SILAC data showing that catalytic
histone methylation is altered late (at E240) but not early (at E30) after quiescence exit (Fig.
2.3B).

Figure 2.6. Box plot analysis shows distinct dynamics of histone acetylation and methylation at
growth and stress genes during the early exit.
H3K9ac drops at stress genes (A) between Q and E30 and increases at growth genes (B) between Q and
E30. In contrast, H3K4me3 and K36me3 remain constant at both stress and growth genes between Q and
E30.

39

Indeed, further analysis of the ChIP-seq histone modification profiles at growth genes
confirms stark dissimilarities during the exit. The dynamic histone acetylation profiles at these
genes correlate with gene expression changes upon nutrient-induced cell cycle re-entry (Fig.
2.1C; Fig. 2.7A). In proliferating cells, such a correlation is also found between histone
methylation and growth gene expression (Fig. 2.1C; Fig. 2.7B, left). However, the altered
methylation profiles in the quiescent state Q remain unchanged in the early exit E30: even though
both acetylation and expression of growth genes are greatly increased in the early exit E30, their
methylation profiles remain unchanged (Fig. 2.7B, right) and do not correlate with gene
expression in the early exit E30 (Fig. 2.7C).

Figure 2.7. Scatterplot analyses demonstrate distinct dynamics of histone acetylation and
methylation at growth genes.
(A, B) Scatterplots contrasting the enrichment of H3K9ac (A) and H3K36me3 (B) at growth genes: histone
acetylation correlates well between LOG and E240 cells (A, orange), but not between Q and E30 cells (A,
blue). In contrast, histone methylation not only correlates well between the LOG and E240 time points (B,
orange), but also between Q and E30 (B, blue), which illustrates that histone methylation remains static in the
early exit. (C) Growth gene expression levels (y-axis) and H3K36me3 enrichment (x-axis) do not correlate in
the early exit from quiescence when growth genes are induced and methylation remains stable. Each dot
represents one growth gene.
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Figure 2.8. H3K36me3 retained at growth genes in quiescent yeast is required for rapid
transcriptional activation during exit.
(A) Growth gene expression levels (y-axis) and H3K36me3 enrichment (x-axis) do not correlate in the early
exit from quiescence. Many growth genes are induced while methylation remains stable (black). A set of
growth genes does not follow this trend and partially retain their histone methylation throughout quiescence
and the early exit (red). Each dot represents one growth gene. (B) RT-qPCR analysis in wildtype and H3K36A
mutant yeast shows that growth genes that naturally lose methylation in wildtype quiescent cells (NSR1 and
NOP1) are induced normally in the H3K36A mutant strain upon refeeding. (C) In contrast, the re-feeding
induction kinetics of growth genes that naturally retain methylation during quiescence (RPL33B, RPP0, and
RPL11B) are delayed in the mutant strain compared to wildtype cell. Asterisks indicate significance.

Interestingly, while methylation is largely unchanging through quiescence exit, it is indeed
present over several growth genes even in quiescence (Fig. 2.8C, red dots). Thus, we were
intrigued at the possibility that histone methylation may be retained at certain growth genes to
assist in rapid transcriptional induction upon quiescence exit. To examine this, we conducted a
time-course expression analysis through quiescence exit using yeast mutants that bear a
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methylation site histone substitution. We sampled certain growth genes that fully lose methylation
(Fig. 2.8C, black dots) to compare them to growth genes that retain methylation (Fig. 2.8C, red
dots) in quiescence, and investigated the induction kinetics of these genes after adding nutrients
to induce cell cycle re-entry. The induction of three genes that typically retain methylation in wild
type cells during quiescence is delayed to varying degrees in the histone mutant expressing
H3K36A (Fig. 2.8D, RPP0, RPL11A, RPL33B, in red shades). In contrast, two genes that largely
lose methylation during quiescence are induced at an earlier time-point and show a profile of
gene activation in the H3K36A cells that is comparable to wild-type cells (Fig. 2.8E, NSR1, NOP1,
in grey shades). Taken together, our ChIP-seq and histone mutagenesis results thus point to
histone methylation functioning as a partial memory mark that facilitates transcriptional induction
of certain growth genes following nutrient replenishment as the cells exit quiescence.
We then investigated histone acetylation and methylation in another group of
environmentally regulated genes that has been previously found to exhibit highly dynamic and
stress responsive histone acetylation induced by H 2O2 treatment92,105. Again, we found that
histone acetylation is rapidly increased at E30 upon nutrient replenishment, whereas histone
methylation remains static and does not follow these dynamics (Fig. 2.9A). As a control, we
determined that neither histone acetylation nor methylation changes at nutrient insensitive genes
during the early exit E30 (Fig. 2.9B).
We then examined methylation patterns over one kilobase windows genome-wide in Q,
E30, E240 and LOG by scatterplot analysis. As expected from the box plot analysis, methylation
patterns are highly correlated between E240/LOG and Q/E30, but are very different between
Q/LOG (Fig. 2.10A, top panels). Prominently, the correlation of genome-wide H3K36 methylation
between Q/E30 (Fig. 2.10A, top right) is strikingly contrasted in by the highly dissimilar H3K9
acetylation pattern between Q/E30 cells (Fig. 2.10A, lower right).
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Figure 2.9. Histone acetylation and histone methylation levels at stress-responsive RRPE/PAC
and nutrient-insensitive genes in quiescence and cell cycle re-entry.
(A) Genes that are characterized by the presence of RRPE and PAC promoter elements exhibit dynamic
changes in histone acetylation, but not histone methylation. In quiescent cells, H3K9ac is greatly diminished,
but rapidly increases at E30 upon nutrient replenishment. H3K4me3 does not follow these dynamics and
remains unchanged in the early exit (264 genes; RRPE - rRNA processing element; PAC - polymerase A and
C). (B) Both histone acetylation and methylation remains largely unaffected at nutrient-insensitive genes in
the early quiescence exit.
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Figure 2.10. Histone methylation patterns correlate genome-wide in quiescence exit.
(A) Genome-wide ChIP-seq enrichment correlations can be seen between proliferating cells (LOG) and cells
in late quiescence exit (E240) for both H3K36me3 and H3K9ac. The H3K36me3, but not H3K9ac, enrichment
pattern is highly correlated in quiescent yeast (Q) and early exit (E30). Each dot represents a 1000 base pair
window of the genome. (B) Genes enriched for H3K36me3 in proliferating cells (LOG) and genes methylated
in late exit cells (E240) cluster into shared GO categories (see Suppl. Table 1; categories are related to growth,
e.g. regulation of translation, ribosome biogenesis, nuclear export). Genes that are methylated in quiescent
(Q) and early exit cells (E30) also share GO categories (related to stress, e.g. cell death, response to abiotic
stimuli). Genes enriched for H3K9ac in quiescent cells (Q) cluster into stress categories that are not shared
by genes that are acetylated in E30, E240, or LOG (see Suppl. Table 2). Genes that are acetylated in E240
and LOG cluster into shared categories that are linked to ribosome biogenesis and translational regulation.
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We further investigated the relationship of histone methylation enrichment to different
gene families, examining H3K36me3 during LOG/Q/E30/E240 using unbiased gene ontology
(GO) enrichment analysis. We queried GO terms that link to the top methylated genes; we found
that LOG cells and E240 cells share categories that are related to cell growth and proliferation
(Fig. 2.10B, left, red and grey circles). Remarkably, genes that are methylated in Q and E30
share GO terms associated with stress (Fig. 2.10B, left, blue and orange circles), despite their
decidedly distinct expression and histone acetylation profiles. In contrast, GO terms that link to
the top acetylated genes in Q do not overlap with GO terms associated with genes that are
acetylated in the early exit E30 (Fig. 2.10B, right).
Thus, by ChIP-seq, we uncovered genome-wide changes in histone methylation that are
obscured in western and SILAC analyses. First, during quiescence establishment, our genome
wide analysis revealed that stress genes become methylated when their expression is induced,
whereas growth genes experience extensive methylation losses when they are not transcribed.
Second, during exit, ChIP-seq revealed two key features of the location of dynamic histone
methylation changes determined by SILAC: (1) quiescence-specific methylation patterns remain
remarkably intact through early exit E30, but (2) change in the course of replication initiation at
E240, when de novo histone methylation occurs exclusively at growth genes. These results, taken
together with our SILAC analyses above, underscore the differences in the roles of histone
methylation and acetylation in the dramatic gene expression changes following quiescence exit.
Histone acetylation rapidly responds to metabolic state, but histone methylation remains stable
through quiescence exit and undergoes genome-wide re-distribution with de-novo growth gene
methylation linked to the initiation of cellular replication.
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DISCUSSION
The epigenome is hypothesized to provide an interface between the cellular environment
and gene expression. One of the most important environmental factors that must be synchronized
with gene transcription is the availability of caloric energy. Indeed, glucose-derived acetyl-CoA is
thought to function as a modulator of histone acetylation and growth-related gene expression 38.
Previous studies suggest that histone acetylation is exquisitely responsive to the nutritional state
of cells. In fact, our findings from SILAC demonstrate that certain histone acetylation sites and, by
default, their acetylation enzymes operate as bona fide energy sensors, providing unequivocal
evidence that nutrients induce an immediate histone acetylation response, driven by external
glucose (Fig. 2.3A).

Figure 2.11. Schematic model for the distinct dynamics of histone methylation and acetylation
during quiescence establishment and exit.
The methylation landscape is changed genome-wide in cellular quiescence. In nutrient-induced cell cycle reentry, this methylation pattern remains strikingly intact – in contrast to dynamic histone acetylation that is
linked to gene transcription. Upon cell cycle return, the methylation landscape is restructured only very late in
conjunction with genome replication and ensuing cell division.
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Histone methylation also has an important role in gene regulation in all eukaryotes.
Chemically, methylation is more stable than acetylation and is known to be less dynamic in cells.
Hence, a key question is whether histone methylation responds to nutritional status. Like histone
acetylation, histone methylation is speculated to be synchronized with metabolic information in
order to regulate gene expression 19,94,99. Here, we performed a comprehensive investigation of
methylation profiles during quiescence exit, when cells undergo a dramatic shift in gene
regulation as a result of the drastic change in metabolic state from nutrient starvation into
regrowth. We observe that histones become enriched for acetylation at certain genes both
globally (by western blot) and locally (by ChIP-seq). Indeed, similar observations have
represented a paradigm for how metabolic changes can alter the epigenome 38,39. Our rigorous
examination, additionally by SILAC, fully confirms that histone acetylation responds immediately
to increased nutrition after starvation. Thus, this nutrient-induced transition from quiescence to
proliferation represents an ideal scenario to examine metabolic signaling to histone methylation.
Histone methylation as an epigenetic memory mark during metabolic shifts
To investigate histone methylation during quiescence exit, we used three approaches: (1)
western blot analysis with methyl-specific antibodies, as was previously used to demonstrate
global changes in histone acetylation 39, (2) quantitative mass spectroscopy using heavy-labeled
precursors to distinguish new histone methylation immediately following re-feeding, and (3) ChIPseq with methyl-specific antibodies, as was previously used to examine site-specific acetylation in
metabolic cycling yeast 38. Interestingly, we found that histone methylation, irrespective of the
residue or methylation states, is exceptionally stable, and is uncoupled from rapid changes in the
metabolic state as cells exit quiescence (Fig. 2.3B). Western blot and SILAC show that the overall
global levels of methylation do not change and do not turnover as the cells emerge from
quiescence. Furthermore, ChIP-seq revealed that there are no localized changes in genomic
distribution during quiescence exit until cell replication commences. In contrast, these same
approaches provide clear evidence that histone acetylation is dynamic: new acetylation is
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detected by SILAC immediately following re-feeding and well before replication (Fig. 2.4). Finally,
ChIP-seq shows that acetylation is rapidly enriched at genes that are induced and depleted at
genes that are repressed.
Thus, our observations revealed that yeast cells that return to the cell cycle in nutrient-rich
conditions exhibit a strikingly stable methylation landscape despite major metabolic and
transcriptional reprogramming. Historically, histone methylation is thought to be a static
modification based on studies that have demonstrated similar turnover rates for methyl groups
and histone proteins 106,107; however, in the past decade, the notion that histone methylation is
enzymatically irreversible has been challenged by the identification of numerous HDMs,
specifically the lysine-specific demethylase 1 (LSD1) and Jumonji C demethylases

41,108,109.

Remarkably, both domain classes of HDMs require high-energy metabolic cofactors – flavin
adenine dinucleotide (FAD) and alpha ketoglutarate (a-KG), respectively. Thus, the coenzymes of
both HMTs and HDMs are positively regulated by high energy levels, an apparent paradox that
likely imposes further regulation should these enzymes be integrated in metabolic control. In
contrast, HATs and HDACs are regulated by high and low energy levels, respectively, adapting
histone acetylation to dynamic metabolic processes through acetyl-CoA generation and the
cellular redox state.
Our results confirm that histone acetylation quickly drives growth gene transcription in
relation to transient caloric availability when emerging from quiescence, whereas histone
methylation remains surprisingly static during the early exit. We cannot exclude the possibility that
metabolic fluxes may directly modify methylation later, i.e. during cell replication when we detect
new methylation. Thus, histone methylation may not play a role in the initial re-activation of
growth genes, but may function in the late cell cycle re-entry to provide transcriptional marking
and coordinate gene expression following genome replication. This is a particularly intriguing
possibility, given our observation of de-novo methylation late after quiescence exit.
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Furthermore, our results show that histone methylation is indicative of transcriptional
potential but not necessarily current transcriptional activity. Indeed, we confirm that enrichment of
H3K4me3 at promoters correlates with gene activity in proliferating yeast

110,111;

however, we also

show that H3K4me3 does not directly correlate with gene expression in the quiescent cell state,
(i.e. we detect H3K4me3 at both active stress genes and inactive growth genes). In fact, previous
observations in mammalian cells showed that H3K4me3 is actually present at a majority of
promoters and is not strictly predictive of transcriptional activity 112,113.
In summary, we find that acetylation is lost nearly completely at growth genes during
quiescence and – driven by metabolic state - is very rapidly reinstated in the early exit. In
contrast, full re-methylation at growth genes occurs only at the time of cell replication following
quiescence exit. Accordingly, although diet, exercise, and circadian rhythms are all known to
readily manipulate histone acetylation to maintain metabolic homeostasis, they may not easily
modify long-term histone methylation.

Histone methylation in the context of altered metabolism in cancer and stem cells
It is interesting to compare our results with recent investigations of histone methylation in
higher eukaryotic cells in the context of proliferative states. In many cancers, deregulated histone
methylation has been implicated in tumorigenesis

29,30.

In a variety of tumors, the metabolic

enzymes isocitrate dehydrogenase 1 (IDH1) and IDH2 were found to bear mutations that result in
neomorphic activities that generate 2-hydroxyglutarate (2HG) 31. As an oncometabolite, 2HG
inhibits a family of Jumonji-C domain histone demethylases (JHDMs) and is thought to disrupt
gene expression patterns through alterations in the histone methylation landscape

31.

In addition, recent findings suggest a mechanistic link between reprogrammed cancer
metabolism and an altered methylation landscape

114.

Certain cancer cells aberrantly express

high levels of the metabolic enzyme nicotinamide N-methyltransferase (NNMT) and exhibit global
methylation defects when methionine is limited. Under these conditions, the increased catalytic
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capacity of NNMT may drain cellular SAM pools by creating stable 1-methylnicotinamide and
thereby impairs histone and other protein methylation

114.

However, it is unclear when, during the

cell cycle, elevated NNMT activities may actually affect histone methylation, and how broad
alterations in the methylation landscape eventually promote oncogenesis. Therefore, in order to
develop novel therapeutic approaches that target cellular metabolism and alter the tumor
epigenome, it is key to understand how chromatin may be metabolically regulated in noncancerous cells.
Interestingly, histone methylation may not only be influenced by metabolic alterations in
tumors, but may also be manipulated by metabolic adaptations in stem cells, where methylation
has critical functions in transcriptional regulation and self-renewal 115,116. Current evidence
suggests that the pluripotency of mouse embryonic stem cells (ESCs) is dependent on their
distinct mode of threonine catabolism and its effect on SAM metabolism and H3K4me3

101.

When

proliferating mESCs are cultured in threonine-depleted media, SAM levels become lowered and
H3K4me3 levels – but not other methylation – decrease, which results in slowed growth and
increased differentiation 101. However, as threonine dependency is specific to mouse ESCs, it
remains unclear whether histone methylation is similarly influenced by metabolic activities in other
stem cell populations like human ESCs or adult human stem cells. Notably, histone methylation
may be under metabolic influence only at specific times, e.g. when quiescent adult human stem
cells are induced to return to the cell cycle and initiate cell replication for clonal expansion.
From our findings in the yeast model, histone methylation may also have distinct
functions from those of histone acetylation in the orchestrated cell cycle re-entry in induced stem
cells, fibroblasts, or lymphocytes. Unlike acetylation, methylation may regulate gene expression
independently of the metabolic milieu during early cell cycle return. Rather, it may function as an
epigenetic marker of cellular transcriptional identity during genome replication and cell division.

50

MATERIALS AND METHODS
Quiescence establishment and exit protocol. Western blot, SILAC, RNA-seq, and ChIP-seq
experiments were performed in BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0; Invitrogen). To
establish quiescence, yeast cells were cultured in 2% synthetic complete media (SC media; 2%
glucose–0.5% ammonium sulfate–0.2% SCM supplement (Bufferad)–0.17% yeast nitrogen base
(Bufferad)) for 72h before their transfer into water for complete nutrient starvation and quiescence
establishment at 30°C, ensuring a homogenous non-dividing cell population, as previously
described 102. Quiescence exit was induced on day 8 by re-suspending pelleted quiescent cells
into fresh 30°C-prewarmed 2% SC media at OD600 0.4. At the indicated time points, culture
aliquots were taken and cells harvested by centrifugation or microfiltration and stored at -80°C for
subsequent analyses as outlined below.
Yeast whole-cell extract preparation and western blotting analysis. Yeast cells were
harvested by centrifugation at 4,000 rpm for 4 min at 4°C. Cells were washed with ice-cold water
once and broken in 50 mM Tris-HCl (pH 7.4)–300 mM NaCl-0.5% NP40–10% glycerol–1 mM
EDTA (pH 8)-protease inhibitor cocktail (Complete; Roche) using silica beads and bead beater
(Bio-Spec). The lysate was sonicated (Bioruptor; Diagenode) for 5 min and cleared by
centrifugation at 14,000 rpm at 4°C for 15 min. The supernatant was collected and stored at
−80°C. Protein estimation was determined using Bradford dye. Extracts were resolved on SDSpolyacrylamide gels, western blotting performed by standart methods and images of the western
blots were taken with a Fujifilm LAS-4000 imager.
Antibodies. The primary antibodies used are as follows: anti-H3 (Abcam, ab1791, 1:1000), antiH3K9ac (Active Motif, 39137, 1:1000), anti-H3K4me1 (Abcam, ab8895, 1:500), H3K4me2 (Active
Motif, 39141, 1:1000), anti-H3K4me3 (Abcam, ab8580, 1:1000), anti-H3K36me1 (Abcam,
ab9048, 1:1000), anti-H3K36me3 (Active Motif, 61101, 1:1000), anti-H3K79me3 (Abcam,
ab2621, 1:1000), anti-H4K5ac (Millipore, 07-327, 1:1000), anti-H4K8ac (Millipore, 07-328,
1:1000).
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Cell culture and SILAC. For the methyl-SILAC and lysine-SILAC time course experiments,
quiescent cell cultures were pelleted at 4,000 rpm for 3 min at 30°C and resuspended with 2%
SC media that was depleted of unlabeled methionine or lysine (SC Dropout Mixtures, Sunrise
Science Products) and supplemented with equimolar amount of L-methionine-methyl-13CD3
(Sigma-Aldrich) or 13C615N2 -lysine (Cambridge Isotope Laboratories), respectively. In order to
assess histone acetylation turnover by heavy glucose-SILAC, quiescent cells were resuspended
in SC media supplemented with 2% of isotopically heavy 13C6-glucose (Sigma-Aldrich). Aliquots
were taken at the indicated time points, and cells collected by centrifugation at 4,000 rpm for 3
min, flash frozen, and stored at -80°C for the subsequent nuclei preparation and histone protein
purification as outlined below.
Purification of histone proteins for mass spectrometry. Preparation of nuclei was based on
published methods 117,118. In brief, 1010 cells were washed in 1 M Sorbitol–50 mM potassium
phosphate (pH 6.8)–14 mM β-mercaptoethanol at 30°C. In order to achieve complete digestion of
the cell wall, cells were resuspended in the same buffer supplemented with Zymolase 100T (0.4
mg/ml) at 30°C for 30 min to 1.5 h. The digestion was monitored by adding 1% SDS to 20 μl of
the digestion reaction and considered complete once the OD600 dropped by 95%. Spheroplasted
cells were washed in 1 M sorbitol, and cell lysis was achieved in 18% Ficoll–20 mM potassium
phosphate (pH 6.8)–1.0 mM MgCl2–0.5 mM EDTA–100 mM Na butyrate–protease inhibitor
cocktail (Complete; Roche) by 60 strokes of Wheaton Dounce homogenizer on ice. Nuclei were
collected after centrifugation at 4000 rpm from supernatant and pelleted by ultracentrifugation at
50,000 x g for 30 min at 4°C. Pelleted nuclei were resuspended in 0.34 M Sucrose–20 mM TrisHCl (pH 7.4)–50 mM KCl–5.0 mM MgCl2 and purified by ultracentrifugation on 2 M sucrose
cushion at 30,000 x g for 30 min at 4°C. Acid extraction to enrich for basic histone proteins was
achieved by resuspending nuclei in 10 mM Tris-HCl (pH 8.0)–400 mM NaCl–100 mM Na butyrate
after three washes in 10 mM Tris-HCl (pH 8.0)–0.5% NP40–75 mM NaCl–100 mM Na butyrate,
and protein precipitation by addition of 20% trichloroacetic acid (TCA), followed by centrifugation,
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and two washes in acetone–0.1% HCl and acetone alone. The pellet was briefly dried, and
proteins were resuspended in water for derivatization.
Histone sample preparation for mass spectrometry. Purified histones were derivatized with
propionic anhydride and digested with sequencing grade trypsin as described before 26,119. Due to
the relative hydrophilicity of the H3 3-8 peptide spanning H3K4 and thus reduced retention and
resolution using reversed phase liquid chromatography (unpublished data), aliquots from the
same histone protein sample were derivatized with benzoic anhydride rather than propionic
anhydride. After derivatization with either reagent, both sample preparations were separately
diluted in 0.1% acetic acid for desalting before mass spectrometric (MS) analysis using
homemade C18 STAGE tips as previously described

119.

Mass spectrometry analysis and peptide quantification. Histone peptides were loaded by an
Eksigent AS2 autosampler onto silica capillary C18 columns and resolved by an Agilent 1200
binary HPLC system as previously reported

26.

Peptides were electrosprayed into a linear

quadrupole ion trap-Orbitrap mass spectrometer. All MS and MS/MS spectra were analyzed with
Qual Browser (version 2.0.7, Thermo Scientific) and peptide abundances were obtained by peak
integration of the extracted ion chromatograms as previously described

26.

SAM labeling assay and SAM fluorometry quantification. Cells were harvested by filtration,
and selected reaction monitoring (SRM) analysis by mass spectrometry was performed as
described in Zee et al. 2012 and Bajad et al. 2006 120,121. To quantify SAM levels, the Bridge-It®
SAM fluorescence assay (Mediomics) was used according to manufacturer’s instruction.
RNA preparation, qRT–PCR, and RNA-seq. RNA was purified using the Dynabeads® mRNA
DIRECT™ Kit (61011, Ambion®, Life Technologies) according to the manufacturer's instructions.
For qRT-PCR analysis, reverse transcription was performed using the Applied Biosystems highcapacity RNA-to-cDNA kit (4387406). cDNA was quantified using standard procedures on a
7900HT Fast-Real-Time PCR machine (ABI). During vegetative growth, quiescence, and
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quiescence exit, mRNA levels were normalized to TUB2 and GAPDH. Three independent
biological replicates were analyzed, and each data point acquired by qPCR was the average from
three independent PCRs. Error bars in the figures are standard errors of the means (SEM), and
asterisk designate significance (*p≤0.01, **p≤0.001). ANOVA analyses assessed the significance
of gene expression defects in the histone mutant (p value in the panels). RNA-seq libraries were
prepared using the ScriptSeq™ v2 RNA-Seq Library Preparation Kit (SSV21124, Epicentre)
according to the manufacturer’s recommendations, and sequencing was performed on the
Illumina Hi-Seq (50 bp single-end reads) platform. RNA-seq data were aligned using the software
TopHat 122, and gene expression levels and differences were calculated using Cuffdiff

123.

Reads

per million reads sequenced per kilobases of exons in the transcript (RPKM) values for exit and
log phase samples were normalized to quiescence scores, log-transformed and visualized using
the Partek Genomics Suite™ (Partek Incorporated).
ChIP-seq. Approximately 50 OD600 units of cells were cross-linked in 1% formaldehyde for 10
min at 25°C, quenched with addition of glycine to 125 mM for 5 min at 25°C, and washed with
water. Cells were resuspended in FA lysis buffer 50 mM HEPES (pH 7.5) –150 mM NaCl–2 mM
EDTA–1% Triton X-100–0.2% SDS–CPI Mini EDTA- protease inhibitor cocktail (Complete;
Roche). One milliliter of silica beads was added to each tube, and cells were disrupted twice for 3
min each for the LOG sample and four times for 3 min each for the Q, E30’ and E240’ samples at
maximum speed with intermediate incubation at −20°C for 3 min (Mini-Beadbeater 96;
Biospec). Chromatin was washed twice with FA lysis buffer and sonicated for 30 cycles (30 s
“on” at high level and 30 s “off” per cycle) (Bioruptor; Diagenode). Cellular debris was removed by
centrifugation at 14,000 rpm for 15 min at 4°C. ChIP was performed as previously described

124;

ChIP using H3K9ac and H4K12ac antibodies for quiescence extracts were completed with 5-fold
the input used for all other ChIP experiments. Per each ChIP, 30 μl of Protein G Dynabeads
(Invitrogen, 100.02D) were prepared using 5 μg of antibody. Controls with IgG and no antibody
were routinely performed. The ChIP DNA was used to make sequencing libraries using standard
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Illumina library single-end construction procedures. Sequencing was performed on the Illumina
Hi-Seq (50 bp single-end reads) platform.
Sequencing analysis. ChIP-seq reads were aligned to the sacCer2 assembly of the S.
cerevisiae genome using the Bowtie alignment software 125. For growth and stress gene boxplot
analysis, each gene of the respective group was assigned a score by computing the area-underthe-curve (AUC) of the ChIP-seq signal over the gene body (H3K36me3), or TSS+/-250bp
(H3K4me3, H3K9ac, H3K12ac). Scores for a given locus in a given state were computed by
normalizing the number of tags aligned to the locus by the total number of bases sequenced perbarcoded sample as well as by total histone and locus length. Boxplots were generated in R.
Yeast transcription start site (TSS) and open reading frame (ORF) locations were obtained by
querying the Ensembl database (www.ensembl.org).
Gene Ontology and Venn diagrams. Gene Ontology (GO) analysis was performed using
DAVID (http://david.abcc.ncifcrf.gov/). The GO terms were clustered using the tool VENNY
(http://bioinfogp.cnb.csic.es/tools/venny/), and Euler diagrams were generated using the
EulerAPE drawing tool (http://www.eulerdiagrams.org/eulerAPE/) that were subsequently edited
for color in PowerPoint 2010 (Microsoft).
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CHAPTER 3
ACETYL-COA METABOLISM BY ACSS2 REGULATES
NEURONAL HISTONE ACETYLATION AND LONG-TERM MEMORY
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ABSTRACT
Metabolic production of acetyl-CoA has been linked to histone acetylation and gene
regulation, however the mechanisms are largely unknown. We show that the metabolic enzyme
acetyl-CoA synthetase 2 (ACSS2) is a critical and direct regulator of histone acetylation in
neurons and of long-term mammalian memory. We observe increased nuclear ACSS2 in
differentiating neurons in vitro. Genome-wide, ACSS2 binding corresponds with increased histone
acetylation and gene expression of key neuronal genes. These data indicate that ACSS2
functions as a chromatin-bound co-activator to increase local concentrations of acetyl-CoA and to
locally promote histone acetylation for transcription of neuron-specific genes. Remarkably, in vivo
attenuation of hippocampal ACSS2 expression in adult mice impairs long-term spatial memory, a
cognitive process reliant on histone acetylation. ACSS2 reduction in hippocampus also leads to a
defect in upregulation of key neuronal genes involved in memory. These results reveal a unique
connection between cellular metabolism and neural plasticity, and establish a link between
generation of acetyl-CoA and neuronal chromatin regulation.
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INTRODUCTION
Memory formation is manifested in long-lasting synaptic restructuring requiring
coordinated expression of neuronal genes126,127. The regulatory mechanisms that control
neuronal gene transcription during memory formation include chromatin-modifying processes that
are incompletely understood47,128. Histone acetylation, one of the best-characterized chromatin
regulatory mechanisms, has emerged as a regulator of memory storage44.

Early studies showed that, following training, chromatin becomes progressively
acetylated in specific brain regions involved in learning and memory, and prominently in the
hippocampal formation59. More recent studies confirm that transcriptional regulation by histone
acetylation is critical to long-term memory consolidation. In particular, the transcription factor
CREB and its coactivator CREB binding protein (CBP) have been linked to synaptic plasticity129.
Indeed, the histone acetyltransferase (HAT) activity of CBP is required for long-term memory
consolidation51,52,69. In addition, intra-hippocampal injections of histone deacetylase inhibitors
enhance memory consolidation50. However, in spite of these important observations, a
comprehensive understanding of the complex mechanisms that regulate neuronal histone
acetylation in long-term memory remains elusive.
Recent studies have identified a new paradigm of transcriptional regulation, based on
direct sensing of intermediary metabolites by chromatin-modifying enzymes such as
acetyltransferases to dynamically adapt chromatin structure and gene expression 15,18. Histone
acetylation can be readily manipulated by altered intracellular pools of acetyl-CoA, the key
metabolite used as a cofactor in all protein acetylation37,38,130. Accordingly, metabolic enzymes
that provide nuclear acetyl-CoA have been postulated to directly control chromatin acetylation
and, consequently, gene expression19,131.
In mammalian cells there are two enzymes that principally generate nuclear acetyl-CoA
to contribute to histone acetylation: acetate-dependent acetyl-CoA synthetase 2 (ACSS2) and
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ATP-citrate lyase (ACL), which uses mitochondria-derived citrate to generate acetyl-CoA79. The
relative importance of these producers of acetyl-CoA for nuclear histone acetylation apparently
differs by tissue type, developmental state, and disease79. Interestingly, while ACL is important for
global histone acetylation in non-neuronal cell lines, contributions by ACSS2 are secondary in
these proliferating cells37. Indeed, the relative roles of ACL and ACSS2 for chromatin acetylation
in post-mitotic neuronal cells remains to be elucidated.
Based on high levels of ACSS2 in mouse hippocampus (Allen Brain Atlas 132), we
investigated a neuronal role for ACSS2 in histone acetylation and gene expression and
hypothesized that it may directly associate with chromatin to locally fuel catalytic HAT activity.
Our results suggest a strong correlation between acetate metabolism and neuronal chromatin
regulation, and provide evidence for direct chromatin association of ACSS2 connected to upregulation of neuronal gene expression. We further demonstrate that hippocampal ACSS2
expression is essential for the acquisition of long-term memories in vivo, a process known to be
dependent on neuronal histone acetylation and gene expression. Together, our observations
provide novel and fundamental insight into molecular mechanisms that underlie neuronal gene
expression and memory consolidation.

RESULTS
ACSS2 is localized to nuclei in differentiated neurons
Neuronal gene transcription underlies memory storage and is regulated by histone
acetylation44. To investigate the neuronal function of the acetyl-CoA-producing enzyme ACSS2,
we used the Cath.-a-differentiated (CAD) cell line, a valuable in vitro model for studies of
neuronal biology133. Upon serum deprivation in culture, these CNS catecholaminergic cells
undergo morphological differentiation to form neuronal processes134. Electrophysiological
characterization confirms that differentiated CAD neurons are excitable and behave similarly to
fully functional neurons, indicating that they capture key aspects of neuronal biology135,136.
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Figure 3.1. ACSS2 localizes to the nucleus upon CAD neuron differentiation.
(A) Subcellular localization of ACSS2 in CAD cells was imaged by immunofluorescence microscopy. Nuclei
and cytoplasm are visualized by DAPI (4´,6´-diamidino-2-phenylindole) stain and α-Tubulin immunostaining,
respectively. (B) ACSS2 immunostaining shows that ACSS2 localizes to the nucleus of differentiated CAD
neurons (5 days post-serum withdrawal). (C) Western blot analysis of whole cell lysates in undifferentiated
CAD cells and differentiated CAD neurons for ACSS2, ACL, β-actin, and Histone H3. (D) Western blot analysis
of nuclear protein extracts shows that ACSS2 protein expression is increased in nuclei of differentiated CAD
neurons. (E, F) Immunofluorescence in primary hippocampal neurons isolated from C57BL/6 embryos at day
7 (E) and day 14 (F) of in vitro differentiation culture. ACSS2 locates predominantly to nuclei in differentiated
primary neurons. (G) Immunofluorescence shows that ACL is chiefly localized to the cytoplasm of primary
hippocampal neurons.

We examined the subcellular localization of ACSS2 in CAD neurons using deconvolution
microscopy and imaged endogenous ACSS2 protein expression by immunofluorescence. In
undifferentiated CAD cells, ACSS2 expression is observed primarily in the cytoplasm with only a
small fraction in the nucleus (Fig. 3.1A). Upon CAD neuronal differentiation a striking change
occurs where ACSS2 becomes primarily localized to the nucleus (Fig. 3.1B). To confirm
relocalization of ACSS2 upon differentiation, we assessed ACSS2 protein levels by western blot
analysis of whole cell lysates and nuclear extracts. Whole cell levels of ACSS2 protein increased
upon CAD neuronal differentiation (Fig. 3.1C), associated with higher levels of ACSS2 protein in
the nuclear extract (Fig. 3.1D).
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We used immunofluorescence to determine whether ACSS2 is also localized to the
nucleus in differentiated primary neurons. Indeed, ACSS2 localized to nuclei of both hippocampal
and cortical neurons (Fig. 3.1E). Notably, ACSS2 localization persists in nuclei even in
longstanding cultures of differentiated primary neurons (Fig. 3.1F). We assessed the specificity of
this nuclear ACSS2 localization by examining the localization of the enzyme ACL (adenosine
triphosphate (ATP)–citrate lyase), which also supplies acetyl-CoA in mammalian cells, by
conversion of mitochondria-derived citrate to acetyl-CoA37. In contrast to what we observed for
ACSS2, immunofluorescence of ACL showed predominant localization in the cytoplasm of
primary neurons, with only a small amount of protein in the nucleus (Fig. 3.1G). Additionally, in
contrast to ACSS2, ACL protein expression does not become upregulated during CAD neuronal
differentiation (Fig. 3.1C). Based on these results, we conclude that ACSS2, in contrast to ACL, is
primarily localized to the nuclei of differentiated neurons.
ACSS2 regulates neuronal gene expression

We assessed global gene expression changes upon neuronal differentiation in CAD cells,
via mRNA-seq. RNA-seq tags were aligned to the mm10 reference genome, and mapped to
genomic features using cufflinks (n=2; replicates are highly correlated with spearman r > 0.8; Fig.
3.3C and 3.3F). Transcriptome analysis identified 894 genes upregulated upon CAD cell
differentiation (Fig. 3.2A; red dots depicting genes with >1.6-fold increase). As anticipated, genes
upregulated upon differentiation are neuron specific; Gene Ontology (GO) analysis revealed
enrichment for genes involved in neuron differentiation, synaptic transmission, ion transport, and
neuron projection morphogenesis (Fig. 3.2B; fold enrichment > 3.5, FDR < 0.005).
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Figure 3.2. ACSS2 supports neuronal gene expression.
(A) RNA-seq identified 894 genes that become upregulated in differentiated CAD neurons (red dots depict
genes with >1.6-fold increase). (B) Gene ontology (GO) enrichment analysis. Functional categories of
upregulated genes are shown, as assigned by DAVID 6.7 (FE > 3.5, FDR < 0.005). (C) ChIP-seq was
performed to reveal regions occupied by H4K12ac, H4K5ac, and H3K9ac in undifferentiated and differentiated
CAD neurons. RNA-seq and ChIP-seq UCSC genome-browser track view with annotations of mm10 genomic
transcript loci, over Nudt1 locus (chr5: 140,327,500-140,339,000). (D) CAD cells were infected with lentiviral
control or knockdown vector. Western blots of nuclear lysates from stably infected cells were probed with the
indicated antibodies. (E) ACSS2 knockdown results in reduced induction of neuronal gene expression
program. Scatter plot contrasts the fold-change FPKM of upregulated genes from (A) between WT and ACSS2
knockdown. Marginal distributions show histogram and kernel density estimation. Ordinary least squares
linear regression is displayed with 95% confidence interval. (F) Same as (E) but comparing fold-induction in
WT to ACL knockdown. (G) Quintiles of upregulated genes (red dots in Fig. 3.2A) with the greatest fold-change
increase in WT. (H) Corresponding gene quintiles depict fold-change FPKM in ACL and ACSS2 knockdown.

Typically, transcriptionally active genes are characterized by increased levels of histone
acetylation that dynamically upregulate gene expression via altered chromatin structure and
recruitment of transcription factors and cofactors. To determine whether histone acetylation is
changed at neuronal genes upon CAD differentiation, we performed chromatin
immunoprecipitation followed by high-throughput DNA sequencing (ChIP-seq) for several key
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histone acetylation sites associated with transcription: acetylation of lysine 9 on histone H3
(H3K9ac), and acetylation of lysines 5 and 12 on histone H4 (H4K5ac and H4K12ac,
respectively). ChIP-seq for total histone H3 and sequencing of input DNA served as normalization
controls (see Experimental Procedures for additional details). All three histone acetylation
modifications greatly increased at the upregulated neuronal genes during CAD cell differentiation,
as shown in a genome browser track view in Fig. 3.2C (compare undifferentiated to differentiated
tracks for each modification at Nudt1, which is upregulated 3.3-fold in the RNAseq dataset).
When compared to all other genes, this set of upregulated and neuron-specific genes is
distinguished by greatly elevated histone acetylation levels (Fig. 3.3G).
Histone acetylation is catalyzed by histone acetyltransferase (HAT) enzymes that depend
on the central metabolite acetyl-CoA as a substrate for their activity. To determine whether
ACSS2-mediated or ACL-mediated acetyl-CoA biosynthesis supports gene expression in CAD
neuron differentiation, we reduced the level of ACSS2 or ACL gene expression prior to CAD cell
differentiation using short hairpin RNAs (shRNA), and validated the knockdown by western blot
(Fig. 3.2D). We performed mRNA-seq in the ACSS2 and ACL knockdown cell lines in duplicate to
determine the transcriptional response upon CAD neuron differentiation (Fig. 3.3A, 3.3B, 3.3D,
3.3E). Computational analysis showed reduced induction of the neuronal gene expression
program described above in the ACSS2 knockdown, as visualized by a low correlation of
transcriptional fold change between ACSS2 knockdown compared to WT cells (pearson r = 0.15;
Fig. 3.2E). This failure of induction was most dramatic when compared to the same analysis for
the ACL knockdown, which retained a much stronger correlation in transcriptional fold change
compared to WT cells (pearson r = 0.53; Fig. 3.2F).
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Figure 3.3. ACSS2 knockdown does not lower global gene expression
(A-C) Correlation plots of replicate RNA-seq in undifferentiated CAD cells for ACSS2 knockdown (A), ACL
knockdown (B), and scramble control (C). (D-F) Correlation plots of replicate RNA-seq in differentiated CAD
neurons for ACSS2 knockdown (D), ACL knockdown (E), and scramble control (F). (G) Bar plot shows the
relative genic enrichment of H3K9ac, H4K5ac, and H4K12ac at genes that are upregulated in the CAD neuron
differentiation (>1.6-fold, grey bars) versus all other genes (black bars). (H) Boxplot of global mRNA transcript
levels in undifferentiated (undiff) and differentiated (diff) CAD neurons from RNA-seq in WT (scramble control
knockdown; grey), ACSS2 KD (shACSS2 #25 knockdown; green), and ACL KD (shACL #17 knockdown; red).
Genome-wide transcript levels are reduced in diff ACL KD when compared to diff WT (p = 1.91e-07, MannWhitney U test).

To more easily visualize the prominent defect in gene expression caused by ACSS2
knockdown, we analyzed transcriptional induction of the genes upregulated in WT CAD neuron
differentiation when stratified into quintiles (Fig. 3.2G-H). In WT neurons, each quintile
represents increased expression fold change (log2 transformed) in the previously described set of
upregulated genes (Fig. 3.2G show the upregulated genes, red dots in Fig. 3.2A). We then
measured the expression fold change of the same genes in either ACSS2 or ACL knockdown
(Fig. 3.2H). ACSS2 knockdown shows highly significant reduction in gene expression induction in
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all quintiles, and this was particularly clear in the top most upregulated quintiles (p = 7.2*10^-252,
Wilcoxon rank-sum test; Fig. 3.2H, green bars compared to wild type quintiles in 2G).
Interestingly, when comparing transcript levels genome-wide, global gene expression was not
lowered in the ACSS2 knockdown in differentiated neurons (Fig. 3.3H). By contrast, in the ACL
knockdown, each quintile shows the same upward trend for expression fold change compared to
WT. However, we note that the overall fold change is lower in ACL than in WT, nonetheless, it
contrasts with the severe defect observed in the neurons harboring ACSS2 knockdown (p =

1.1*10^-25, Wilcoxon rank-sum test; Fig. 3.2H, red bars). In fact, transcript levels were reduced
globally when compared to WT (p = 1.91e-07, Mann-Whitney U test; Fig. 3.3H), contrasting the
more specific and globally far less significant effect in the ACSS2 knockdown (p = 0.04, MannWhitney U test; Fig. 3.3H). Based on these observations, we conclude that ACSS2 is required for
the normal induction of the neuronal gene expression program upon CAD neuron differentiation.
In contrast, although the overall transcriptional response is not as robust as in WT, ACL
knockdown does not abrogate gene induction of neuron-specific genes.
ACSS2 is recruited to transcriptionally active chromatin

The observations from our knockdown experiments indicate that ACSS2 is required for
normal gene induction upon CAD neuron differentiation, and that induced genes acquire
transcription-associated histone acetylation. We investigated whether ACSS2 might directly
associate with neuron-specific genes to increase histone acetylation. We reasoned that direct
recruitment of ACSS2 to genes would both increase availability of acetyl-CoA for catalytic HAT
enzymes, and would also concurrently lower CoA levels (which restricts HAT enzyme activity via
product inhibition), leading to an overall increase in the gene-proximal ratio of acetyl-CoA to CoA.
To test this model of chromatin-localized ACSS2 function, we performed ACSS2 ChIP-seq
experiments to assess its chromatin binding, using two different antibodies in biological replicates
of CAD neuron differentiation.
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Figure 3.4. ACSS2 is recruited to transcriptionally active chromatin.
(A) ChIP-seq in differentiated CAD neurons was performed in replicate with two different antibodies to ACSS2.
Correlation plot displays relative enrichment over corresponding MACS peaks (default parameters with Input
used as control). (B) Distance distribution plot showing frequency of ACSS2 peak to closest gene distance
(1400 peaks total). (C) UCSC Genome Browser views of delta ChIP-seq tracks show that, upon CAD neuron
differentiation, increases in H4K5, H4K12, and H3K9 acetylation over the NUDT1 gene locus co-occur with
ACSS2 enrichment (chr5: 140,327,500-140,339,000). (D) Meta-peak plot displays mean read enrichment over
the center of ACSS2 peaks (intersected set of MACS peaks from ACSS2 CS and T ChIP-seq). (E) Heat-maps
depict enrichment of reads mapped over the ACSS2 peak center (+/- 2kb). (F, G) Intersection of ACSS2 and
acetyl broad peaks using MACS. (H) GO term enrichment analysis of top 5% genes that become ACSS2bound in CAD neuron differentiation. (I) UCSC Genome Browser views of ChIP-seq tracks demonstrate that
increases in H4K5, H4K12, and H3K9 acetylation co-occur with proximate ACSS2 enrichment over the
Camk2a locus upon CAD neuron differentiation (U – undiff, D – diff; chr18: 60,920,000-60,990,000). (J-L)
Violin-contour plots display ChIP occupancy for the indicated percentiles of genes that were ranked according
to dynamic ACSS2 binding upon CAD neuronal differentiation.
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We measured ACSS2 peak enrichment using MACS (see Experimental Procedures for
additional details). Importantly, genome-wide comparison of the separate ACSS2 ChIP-seq
datasets confirmed high correlation both for MACS overlapping peaks (spearman r = 0.82; Fig.
3.4A), and for global enrichment over 1kb genomic windows (spearman r = 0.73; Fig. 3.5A). We
examined whether histone acetylation is increased at sites of chromatin-bound ACSS2, by
comparing to the genome-wide histone H3 and H4 acetylation data from the CAD neuron ChIPseq described above. An example of ACSS2 peak enrichment is shown in the genome browser
track view of the TAB2 (TGF-Beta Activated Kinase 1/MAP3K7 Binding) gene locus, with striking
enrichment in differentiated CAD neurons relative to undifferentiated neurons (Fig. 3.5B). Binding
of ACSS2 upstream of the activated TAB2 gene is concurrent with prominent increases in histone
H3K9, H4K5, and H4K12 acetylation at the Tab2 promoter (Fig. 3.5B). Likewise, at the NUDT1
gene locus, increases in H4K5, H4K12, and H3K9 acetylation that we described earlier (Fig.
3.2C) co-occur with ACSS2 binding upon neuronal differentiation (Fig. 3.3C).
To assess whether chromatin-bound ACSS2 is generally located at or nearby genes in
differentiated CAD neurons, as observed in the case of Nudt1 and Tab2, we inspected the
distribution of ACSS2 peak-to-gene distance genome-wide. Indeed, the largest cohort of ACSS2
peaks are within 1kb of genes in differentiated neurons (Fig. 3.3B). We identified genes that are
closest to ACSS2 peaks (within 10 kb of ACSS2 peak; see Experimental Procedures), and
determined by GO enrichment analysis whether ACSS2 binding is related to the neuronal gene
expression program in CAD cell differentiation. Strikingly, the genes proximal to ACSS2 binding
sites are involved in neuronal differentiation and function, and are enriched for representative
categories such as axonogenesis, neuron projection morphogenesis, and synapse function (Fig.
3.5C). These data suggest that chromatin-associated, promoter-proximal ACSS2 may support
histone acetylation in differentiated neurons as a local source of acetyl-CoA, by supplying
cofactor directly for catalysis by HAT enzymes.
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Based on these observations, we tested whether ACSS2 binding is correlated with locally
increased histone acetylation. Quantitative enrichment analysis revealed that histone acetylation
was markedly increased over all ACSS2 peaks, as evident in a meta-peak plot (Fig. 3.3D).
Importantly, visualization of histone acetylation enrichment over ACSS2 peaks in heat-maps
confirmed that this positive correlation is not produced by a subset of chromatin-bound ACSS2,
but an overall clear trend (Fig. 3.3E). Most importantly, this correspondence is not evident when
histone acetylation peaks are surveyed in their entirety genome-wide, suggesting that ACSS2 is
not simply enriched wherever histone acetylation is present (Fig. 3.5D-G). These data indicate a
positive relationship between ACSS2 binding and increased histone acetylation enrichment
patterns.

Figure 3.5. Relationship between ACSS2 enrichment and increased histone acetylation.
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(A) ChIP-seq in differentiated CAD neurons was performed in replicate with two different antibodies to ACSS2.
Correlation plot displays relative enrichment genome-wide. (B) Overlaid UCSC Genome Browser views of
indicated ChIP-seq tracks in undifferentiated CAD cells (dark shade) and differentiated CAD neurons (light
shade) over Tab2 locus (chr10: 7,875,000-8,004,000). (C) GO enrichment analysis of the genes most
proximate to ACSS2 peaks demonstrates that neuron-specific genes are enriched. (D) Meta-peak plot
displays mean read enrichment over the center of H3K9ac peaks. (E, F) Correlation plots show ACSS2 ChIP
occupancy over H3K9ac broad MACS peaks in undifferentiated CAD cells (E), and in differentiated CAD
neurons (F). (G) Heat-maps depict enrichment of reads mapped over the H3K9ac peak center (+/- 2kb). (H)
Table shows % direct overlap of ACSS2 peaks with H3K9ac, H4K5ac, and H4K12ac broad MACS peaks. (I)
Intersection of ACSS2 and H3K9ac broad peaks using MACS. (J) Discovered de novo motifs for transcription
factor binding sites predicted by HOMER from all ACSS2 ChIP-seq peaks called by MACS in differentiated
CAD neurons.

Next, we examined more closely the amount of overlap between ACSS2 and histone
acetylation peaks. Remarkably, while the majority of ACSS2 peaks are proximal to histone
acetylation peaks, a substantial number – nearly 15% of all ACSS2 peaks genome-wide – directly
overlap with peaks of H3 and H4 acetylation (Fig. 3.5H). Moreover, we found that ACSS2 peak
height is positively correlated with that of intersected histone acetylation peaks, suggesting that
ACSS2 becomes bound to chromatin in proximity to HAT enzymes that enact transcriptionally
activating histone acetylation (Fig. 3.3F, G; Fig. 3.5I). We next explored whether ACSS2 ChIPseq peaks are enriched for particular transcription factor binding motifs, using the motif discovery
tool in HOMER (Fig. 3.5J). We found highly enriched sequences that are specifically bound by
transcription factors typically expressed in neuronal tissue. The motif for transcription factor Yin
Yang1 (YY1) binding was the most significantly enriched motif in this list (Suppl. Fig 3I; YY1, p =
1e-599). Intriguingly, YY1 has been found to exist in a large complex in vivo, and is known to
function in transcriptional activation through recruitment of the two HAT enzymes CBP (CREBbinding protein) and p300137–139. Both of these co-activators depend on acetyl-CoA for their
catalytic activity. Accordingly, chromatin-localized production of acetyl-CoA by ACSS2 may fuel
nearby catalytic HAT activities and support increased histone acetylation.
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Figure 3.6. UCSC Genome Browser views of ACSS2 ChIP-seq data
(A) UCSC Genome Browser views of delta ChIP-seq tracks demonstrate that increases in H4K5, H4K12, and
H3K9 acetylation co-occur with ACSS2 enrichment over the Idua (Alpha-L-iduronidase) gene locus upon CAD
neuron differentiation. (B) At the Slc19A1 (Solute Carrier Family 19 (Folate Transporter), Member 1) gene,
elevated histone H4K5, H4K12, and H3K9 acetylation levels correspond with increasing ACSS2 enrichment
in CAD neuron differentiation.

Importantly, by visual inspection of the histone acetylation and ACSS2 ChIP-seq data, we
further noted the presence of both histone acetylation and ACSS2 peaks with varying shape and
density of reads that are not identified in our MACS peak analysis, likely based on these
variations (Fig. 3.6A, 3.6B; example genome browser track views display occupancy in delta
tracks, i.e. diff subtracted undiff). One example of such enrichment occurs at the gene encoding
for calcium/calmodulin-dependent protein kinase type II alpha chain (CAMKIIA), an enzyme that
is required for hippocampal long-term potentiation (LTP) and spatial learning. At the CAMK2A
gene locus, ACSS2 becomes bound in CAD neuron differentiation and appears to co-occur with
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increases in histone H3K9, H4K5, and H4K12 acetylation, as visualized in the genome browser
track view displaying ChIP occupancy in both the undifferentiated and differentiated state (Fig.
3.3I). We note that this trend is similar to that observed with MACS peaks in our previous
analyses. Thus, to account for both peak and non-peak genic enrichment of histone acetylation
and ACSS2, we further examined histone acetylation and ACSS2 enrichment by meta-gene
analysis. First, we determined whether genes with the greatest ACSS2 enrichment are
characterized by above average histone acetylation levels, to further support our peak analysis
observations. Indeed, gene enrichment analysis revealed that the top 5% ACSS2-enriched genes
maintain histone acetylation that is up to three-fold higher than the mean across all genes (Fig.
3.7A-D). Importantly, we then investigated whether ACSS2 enrichment patterns predict dynamic
changes in histone acetylation. We examined whether ACSS2 binding during CAD neuronal
differentiation correlated with more substantially increased histone acetylation. Strikingly, genes
with the greatest fold-change in ACSS2 binding are distinguished by the highest histone
acetylation levels in differentiated neurons, particularly histone H4 acetylation (Fig. 3.3J-L, Fig.
3.7E-H). Importantly, these top ACSS2-bound genes that experience the largest acetylation gains
are neuron specific, as evident by GO term enrichment analysis (Fig. 3.3H).
In addition, to further show that ACSS2 enrichment is linked to gene expression, we
implemented a multiple linear regression analysis and visualized the interaction between gene
expression changes in the differentiation and binding of ACSS2 to chromatin (Fig. 3.7I). The
contour plot of this model is displayed with the scatter plot of the independent gene expression
variables, predicting higher levels of ACSS2 enrichment in red and lower levels in blue. Indeed,
this fitted regression model confirms a remarkable relationship between higher ACSS2
enrichment and increased gene expression, and displays upregulated genes in correspondence
with elevated ACSS2 enrichment in red (Fig. 3.7I). Thus, taken together with the ACSS2 and
histone acetylation peak analyses, and the RNA-seq results, these genomic data demonstrate
that dynamic ACSS2 enrichment in differentiated neurons is involved in transcriptional regulation,
and that ACSS2 binding is linked to increases in histone acetylation at upregulated genes.
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Figure 3.7. Genic enrichment of ACSS2 corresponds to increased gene expression.
(A-D) Meta-gene enrichment analysis shows ChIP occupancy for ACSS2 (A), H3K9ac (B), H4K5ac (C), and
for H4K12ac (D) across the top 5% of genes enriched for ACSS2 in differentiated CAD neurons (Top 5% DE;
red). The bottom 80% of genes (Bot 80% DE) is shown in blue, and the average signal across all genes (All
genes DE) is shown in green. (E-H) Meta-gene enrichment analysis shows ChIP occupancy for ACSS2 (E),
H3K9ac (F), H4K5ac (G), and for H4K12ac (H) at the top 5% of genes that become dynamically bound by
ACSS2 upon neuronal differentiation (Top 5% DE; red). The bottom 80% of genes (Bot 80% DE) is shown in
blue, and the average signal across all genes (All genes DE) is shown in green. (I) Multiple linear regression
analysis was implemented to model the interaction between genic ACSS2 enrichment and WT gene
expression changes. The contour plot of this fitted regression model displays high levels of ACSS2 enrichment
in red and low levels in blue, and is overlaid with the scatter plot of the independent gene expression variables.
The visualized model demonstrates that high ACSS2 enrichment corresponds to increased gene expression
in the CAD neuronal differentiation.

ACSS2 functions in neuronal histone acetylation

The results presented above suggest that nuclear ACSS2 expression supports neuronal
histone acetylation, and indicate a requirement for ACSS2 in regulating histone acetylation and
neuron-specific gene expression in differentiated neurons. To test whether acetyl-CoA
biosynthesis by ACSS2 is important for neuronal chromatin acetylation, we attenuated ACSS2
expression in CAD neurons and examined global histone acetylation levels by western blot.
ACSS2 knockdown indeed resulted in general reduction of most tested histone acetylation
modifications including dramatically reduced histone acetylation at H4K12 (Fig. 3.8A). In contrast,
ACL knockdown did not affect global levels of histone H4K12 acetylation (Fig. 3.8A), providing

72

further evidence that ACSS2 may be the dominant acetyl CoA supplier for histone acetylation
associated with neuronal gene induction. We note that these ACL results are in contrast to
previously reported data from proliferating non-neuronal cell lines, which have been shown to
primarily depend on ACL to supply acetyl-CoA that participates in histone acetylation 37.
Therefore, it appears that contribution of the catalytic functions of ACL versus ACSS2 to the
supply of nuclear acetyl-CoA required for histone acetylation on chromatin is contingent on both
cell type and state of cellular differentiation. Further, ACSS2 knockdown not only substantially
impairs global H4 acetylation, but also affects histone H3 acetylation, which is linked to
transcriptional activation and typically mediated by HAT enzymes implicated in hippocampal LTP
and memory formation – specifically Gcn5, CBP, and p300 (Fig. 3.8B). These changes show
certain specificity, as global levels of H4K16 or H3K122ac acetylation were not affected by
ACSS2 knockdown (Fig. 3.8B). Additionally, we performed ACSS2 co-IP experiments and found,
in support of our ChIP-seq analyses that ACSS2 pulls down histone proteins and ACSS2 is
preferentially bound to acetylated chromatin (Fig. 3.8C, SN = supernatant).
We explored a potential mechanism by which ACSS2 becomes chromatin-bound and
recruited to transcriptionally active regions leading to increased histone acetylation. As shown
above, ACSS2 knockdown resulted in the pronounced decrease of H3K9 and H3K27 acetylation
(Fig. 3.8B). We reasoned that ACSS2 might physically associate with transcriptional coactivators, such as CBP, which has broad spectrum histone acetyltransferase activity, catalyzing
acetylation of H3K9 and H3K27, as well as other histone lysine residues

140,141.

Furthermore, as

described above, CBP is prominently involved in transcriptional activities that underlie the
formation of long-term memories52,69,142,143. To test whether endogenous ACSS2 interacts with
CBP, we performed co-IP experiments using an antibody against ACSS2. By western blot, we
found that ACSS2 pulls down the co-activator CBP (Fig. 3.8D). Hence, ACSS2 physically binds to
acetylated histones and to CBP, and these associations are consistent with a direct role of
ACSS2 in regulating chromatin to induce neuronal gene expression.
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Figure 3.8. ACSS2 functions in neuronal histone acetylation.
(A) Western blot analysis of whole cell lysates after lentiviral shRNA-mediated knockdown demonstrates that
ACSS2 - but not ACL - reduction lowers H4K12 acetylation. (B) ACSS2 knockdown results in decreased levels
of H3K9 and H3K27 acetylation. Western blot analysis shows that ACSS2 knockdown results in decreased
levels of H3K9 and H3K27 acetylation (whole cell lysates obtained from shCTRL and shACSS2 #25
knockdown cells). (C) Western blot analysis on eluates and supernatants of IgG control and ACSS2 co-IP
experiments indicates that ACSS2 preferentially pulls down acetylated histone proteins. (D) Western blot
analysis of IP eluates shows that CBP is coimmunoprecipitated in the ACSS2 IP, but not in the control IgG IP.

ACSS2 regulates long-term memory storage

Based on our observations in CAD cells, we hypothesized that ACSS2 may play a role in
memory in vivo through support for histone acetylation and transcriptional regulation, which are
required during memory consolidation. ACSS2 is highly expressed in the hippocampal formation
(HPF), including the dorsal CA1 region of the hippocampus proper (Suppl. Fig.6A, right: ACSS2
RNA in situ hybridization on CA1 sagittal section, left: reference atlas; adapted from Allen Brain
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Atlas132), a brain region that is critical for contextual and spatial memory formation 144–146.
Therefore, we tested the requirement for ACSS2 in long-term spatial memory formation, a
hippocampus-dependent process that involves increased histone acetylation and neuronal gene
transcription62,64,143,147. We attenuated hippocampal ACSS2 expression in adult mice by shRNAmediated knockdown. We delivered a viral vector, AAV9-ACSS2 knockdown, into the dorsal CA1
area of the hippocampus, via intracranial injections using stereotactic surgery (Fig. 3.10A; AP, 2.0mm; DV, -1.4mm; ML, +/-1.5mm; C57BL/6J, N = 10 per group).). Behavioral studies began
three weeks post-surgery, at which point Western blot analysis showed reduced ACSS2
expression in the dorsal hippocampus, but not in the ventral hippocampus (Fig. 3.10B).
Importantly, neither control vector injection nor ACSS2 shRNA knockdown injection led to no
apparent deficits in locomotion or coordination (visual inspection), or in body weight by
quantification (Fig. 9B; p = ns, N = 10 per group). Similarly, the mice did not display increased
anxiety, as measured in the open field test148 (Fig. 3.10C, Δ mean = -13.7 ± 17.2, p = ns; Fig.
9C). These results indicate that ACSS2 knockdown does not cause major, broad alterations in
behavior.
To determine the role of hippocampal ACSS2 in transcription-dependent memory, we
assessed long-term spatial memory in control or knockdown mice using an established objectlocation memory task149,150. In this assay, animals explore an arena with three different objects
during training. To test long-term memory formation, the animals are re-exposed to the same
arena 24h later with one object moved to a novel location (see schematic Fig. 3.10A, right). To
diminish preference biases, we performed the spatial memory test on control AAV and ACSS2
knockdown mice on the same day in the same arena, using every combination of location of
objects (N = 10 per group). In the retrieval test, control AAV-eGFP-injected animals displayed a
significant preference for the object moved to a novel location, indicating normal long-term spatial
memory (Fig. 3.10D).
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Figure 3.9. ACSS2 is highly expressed in the dorsal CA1 region of the hippocampus
(A) ACSS2 RNA in situ hybridization on CA1 sagittal section ACSS2 (right; left: reference atlas). From: Allen
Mouse Brain Atlas132. (B) Plot shows weight of eGFP-AAV9 control and shACSS2-AAV9 knockdown mice
before intracranial surgery, and following recovery before OLM task training (p = ns, N = 10 per group). (C)
Bar-plot displays the averaged recorded time the eGFP-AAV9 control and shACSS2-AAV9 knockdown
animals explored the center of the arena in the open field test over five minutes. (D) Table of the exploration
times by eGFP-AAV9 control and shACSS2-AAV9 knockdown mice recorded for the three objects (O1-3)
during the first OLM training session (TR – Training) and the 24h retention test (NL – object in novel location,
FM – objects remained in former location).
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Strikingly, hippocampal knockdown of ACSS2 led to an impairment in hippocampusdependent spatial object memory (Fig. 3.10D, Fig. 9D; mean Δ = -5.01 ± 1.21; p = 8.3e-05).
Importantly, ACSS2 knockdown animals showed a reduction in total object exploration during the
test session suggesting that ACSS2 mice recognized all objects from the training sessions and
express this recognition memory as reduced exploration (mean Δ = -6.13 ± 2.15; p = 0.02). This
spatial memory defect in ACSS2 knockdown animals manifested in significantly lowered
discrimination index (% DI = (t novel – t familiar) / (t novel + t familiar)) when compared to control
AAV-eGFP-injected mice (Fig. 3.10E; % ΔDI = -29.5 ± 11.4; p = 0.02). These results indicate that
ACSS2 is required in the dorsal hippocampus for long-term object-location memory.
Next, we sought to test a type of memory acquisition in the same animals that is
predicted to not be affected by knockdown of ACSS2 in the dorsal CA1. Relevantly, in contrast to
long-term spatial memory, standard contextual fear conditioning is not dependent on the dorsal
hippocampus 151, but instead highly engages the ventral hippocampus 152–154. Importantly, as we
targeted only the dorsal CA1 in our AAV-vector injections, the ventral hippocampus expressed
normal levels of ACSS2 protein, as shown by western (Fig. 3.10B, VH or ventral hippocampus).
The fear conditioning paradigm is a task in which an aversive stimulus (1.5 mA electrical shock) is
associated with a neutral context. Re-exposure to the context prompts retrieval of the memory for
the context-shock association, and is scored as motion freezing. We tested the control-injected
and ACSS2 knockdown animals in this assay (N = 10 per group); the ACSS2 knockdown mice
showed no defect compared to the control vector in contextual fear memory, with average
freezing of 50% after context re-exposure (Fig. 3.10F). Hence, specific knockdown of ACSS2 in
the dorsal hippocampus does not lead to ventral-specific alteration of a fear conditioned memory
response. The results from the two assays show that ACSS2 may play a critical role in the
formation and maintenance of long-term spatial memory - a process that involves rapid elevation
of histone acetylation leading to transcription of immediate-early genes69,143,147,155.
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Figure 3.10. ACSS2 knockdown in dorsal hippocampus impairs object location memory.
(A) Stereotactic surgery was performed to deliver AAV9 knockdown vector into the dorsal hippocampus (AP,
-2.0mm; DV, -1.4mm; ML, +/-1.5mm); four weeks later habituated mice received training for object location
memory (four training sessions of 5 min each in arena with three different objects). 24 hours later the mice
were given a retention test in which one object was moved to a novel location (n = 10 per cohort). (B) Western
blot analysis of hippocampal tissue harvested from animals injected dorsally with either control or ACSS2
knockdown AAV9 (DH – dorsal hippocampus, VH – ventral hippocampus). (C) ACSS2 knockdown animals
showed no defect in the open field test, in which the time the animal explore the periphery of the arena is
recorded over five minutes. (D) Both eGFP-control and shACSS2-AAV9 mice displayed no preference for any
of the three objects (O1-3) during the first OLM training session (TR – Training). During the 24h retention test,
mice that received the shACSS2 knockdown vector displayed no preference for the object move to a novel
location (NL) over the objects that remained in their former location (FM), in contrast to mice injected with the
control eGFP-AAV9 (mean Δ = -5.01 ± 1.21; t-ratio = 4.14, p = 8.3e-05). (E) Lowered discrimination index (%
DI = (t NL – t FL) / (t NL+ t FL)) indicates spatial memory defect in ACSS2 knockdown animals (ΔDI = -29.5 ±
11.4; p = 0.02). (F) Compared to the control eGFP-AVV9 mice, ACSS2 knockdown mice show no defect in
contextual fear memory. Fear memory was measured as the freezing response after re-exposure to the
context 1 day after contextual fear conditioning (1.5 mA electrical shock).
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ACSS2 regulates dynamic upregulation of early response genes in vivo

Following memory acquisition, dynamic changes in gene expression occur within a
sensitive time window to enable the consolidation of long-term memory156. Similarly, following
retrieval of the memory trace, gene transcription is necessary for memory reconsolidation – a
process that is prevented by inhibiting mRNA synthesis during the sensitive post-retrieval
period157,158. We hypothesized that ACSS2 is needed for dynamic upregulation of genes that
mediate hippocampal memory formation and reconsolidation. Genome-wide approaches that
examine memory-related changes in gene expression have long been frustrated by confounding
factors unique to neural tissue, such as extraordinary cell type heterogeneity and functionally
important transcript changes that are far smaller than those observed in peripheral tissues 159.
However, newer studies identified a core gene set that is regulated by contextual conditioning in
the mouse hippocampus during consolidation and post-retrieval156,160.
To test whether the induction of these genes is reliant on ACSS2, we performed mRNAseq on the dorsal hippocampus, i.e. the region targeted in our AAV injections. Hippocampal
tissue was collected from both shACSS2 knockdown and eGFP control animals during the
established sensitive period of one hour after contextual memory retrieval (RT)). Injected animals
that were handled but not trained were dissected at the same time of day in order to control for
circadian gene expression (CC). We focused our transcript analyses on the set of identified early
response genes that have been validated in several studies, and that are regulated during the
sensitive period following memory retrieval156,160–162.
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Figure 3.11. ACSS2 regulates retrieval-induced upregulation of immediate-early genes in vivo.
(A) Genome-wide RNA-seq was performed on the dorsal hippocampus of eGFP control and shACSS2
knockdown animals. The baseline expression of immediate-early genes in untrained animals is not changed
in shACSS2-AAV9 mice when compared to eGFP-AAV9 control mice (CC – circadian control). (B) During the
sensitive period following contextual memory retrieval (RT), immediate-early genes are upregulated in control
injected animals. In contrast, the retrieval-induced expression of these early response genes is absent in
ACSS2 knockdown animals (p = 0.001, Paired T test). (C) Boxplot shows the induction defect of immediate
early genes in shACSS2-AAV9 injected animals (RT/CC). (D) The baseline expression of genes that are
downregulated following contextual memory retrieval is not altered in ACSS2 knockdown animals. (E)
Downregulation of retrieval-responsive genes occurs both in eGFP control and ACSS2 knockdown mice. (F)
Boxplot compares retrieval-responsive downregulation of retrieval-responsive genes in the dorsal
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hippocampus in eGFP control versus shACSS2 knockdown (RT/CC). (G) Boxplot of global transcript levels
shows that genome-wide expression levels following contextual memory retrieval are not affected by ACSS2
knockdown in the dorsal hippocampus. (H) Model: ACSS2 functions as a chromatin-bound coactivator to
locally provide acetyl-CoA to promote histone acetylation and the activity-induced upregulation of immediateearly genes. Accordingly, ACSS2 operates in a salvage pathway to recover both acetate and CoA, the
respective byproducts of the catalytic actions of HDAC and HAT enzymes, and therefore implicates acetate
metabolism in transcription regulation.

Interestingly, baseline expression of these memory-associated genes in the untrained
mice was remarkably similar when comparing shACSS2 knockdown to eGFP control
hippocampus (Fig. 3.11A). In clear contrast, following memory retrieval, expression of these
genes was strongly upregulated in the dorsal hippocampus of eGFP control animals, during the
sensitive period following contextual memory retrieval (Fig. 3.11B and 3.11C). Remarkably, this
dynamic retrieval-induced transcription was absent from most of these early response genes after
knockdown of ACSS2 (p = 0.001, Paired T test; Fig. 3.11B and 3.11C). In contrast, retrievalresponsive genes that are typically downregulated during this same period were not affected by
knockdown of ACSS2 (Fig. 3.11D, 3.11E, 3.11F), with the exception of Cldn5. Additionally, global
expression profiles were strikingly similar across all samples, whereas the group of immediateearly genes was significantly decreased in expression (compare global in Fig. 3.11G to IE genes
in 3.11C). Together, these results demonstrate a crucial role for ACSS2 in the dynamic and
exquisitely timed upregulation of genes that function in long-term memory.

DISCUSSION
A compelling body of evidence suggests an intimate relationship between metabolic state
and chromatin regulation. This link is manifested in key metabolites that participate in biochemical
pathways as intermediates, and function as cofactors to regulate chromatin modifying
enzymes18,163. Most interesting is the metabolite acetyl-CoA, given its central role as an
intermediate of cellular energy metabolism and a key determinant of all chromatin
acetylation37,38,88. Hence, how nuclear acetyl-CoA is regulated to control histone acetylation is
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under investigation, and holds promise for increased understanding of molecular mechanisms
that adapt gene expression to internal and external stimuli. Our study reveals a previously
unknown function of the central metabolic acetyl-CoA source ACSS2 as a chromatin-bound
transcriptional coactivator that stimulates histone acetylation and gene expression.
In recent years, studies have shown that optimal acetyltransferase activity involves
increases in acetyl-CoA. In fact, both the catalytic activity and specificity of HAT enzymes can be
determined by the local acetyl-CoA to CoA ratio130,131. For instance, the substrate selectivity of
the HAT enzymes p300 (E1A binding protein p300) and CBP change with distinct acetyl-CoA
levels164. Adding yet another layer of metabolic regulation of histone acetylation is the polyamine
spermidine – a ubiquitous metabolite involved in chromatin condensation – which competes with
acetyl-CoA for binding to HAT enzymes165. Collectively, these findings suggest that nuclearlocalized metabolic enzymes could increase the local acetyl-CoA concentration by fueling
catalytic activities of proximate histone acetyltransferases and hence promoting gene
transcription. Indeed, in yeast, the nucleocytoplasmic acetyl-CoA synthetase interacts with
subunits of SESAME (Serine-responsive SAM-containing Metabolic Enzyme complex), a protein
complex that is recruited to chromatin by the Set1 methyltransferase 166. In addition, the
mitochondrial pyruvate dehydrogenase complex translocates to the nucleus to support histone
acetylation167, and associates with p300 on chromatin to locally supply acetyl-CoA for histone
acetylation and instantaneously recycle CoA168. Our study provides the first evidence that
localization of an acetyl-CoA metabolic enzyme, ACSS2, directly to specific genes, leads to
upregulation of neuronal histone acetylation and transcription.
Notably, ACSS2 was previously shown to partially localize to the nuclear compartment of
cells37,83, and to contribute to global histone acetylation in low glucose conditions 37. Curiously, in
adipose and malignant cell lines, the major source of nuclear acetyl-CoA contributing to histone
acetylation is ACL, not ACSS237. In contrast, our findings reveal that post-mitotic CAD neurons
preferentially rely on ACSS2 for their supply of acetyl-CoA that feeds into chromatin acetylation.
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These results are consistent with a body of evidence that acetyl-CoA metabolism is highly cell
and tissue specific, and is frequently dysregulated in disease. For example, malignant
transformation renders tumor cells dependent on acetate, and tumors characterized by high
ACSS2 levels are associated with poor disease outcome32,169,170.
Here, we demonstrate that the metabolic enzyme ACSS2 localizes to nuclei of neuronal
cells, and directly associates with chromatin. Intriguingly, such direct regulation of chromatin
acetylation allows for potential rapid and widespread tissue-specific adaptation to changing
environment and metabolic states. In particular, recruiting ACSS2 to chromatin provides a
mechanism for sustaining histone acetylation and gene transcription locally in an otherwise
restrictive metabolic state of low glycolysis, when acetyl-CoA production by citrate-dependent
ACL is reduced. States of low metabolism are produced by fasting, calorie restriction, or exercise,
which promote hepatic β-oxidation of fatty acids and thus increase circulation levels of βhydroxybutyrate (β-OHB), a ketone body that contributes to peripheral acetyl-CoA pools and
plays a central role as an HDAC inhibitor. Interestingly, whereas fasting results in significantly
reduced acetyl-CoA and protein acetylation in most tissues, acetyl-CoA levels in the brain remain
unchanged171. Accordingly, ACSS2 expression may be of particular importance for brain function
in the fasted state, allowing ketone bodies to be sourced for acetyl-CoA production in order to
sustain transcriptionally permissive chromatin and regulated gene expression. Thus, taken
together, our findings are relevant to an adverse set of physiologically normal and abnormal
states, and inform upcoming studies of disease conditions characterized by altered chromatin
acetylation and acetate dependence, including cancer and neurodegenerative disease.
Overall, our study befits the emerging paradigm that metabolite pools function in
chromatin regulation and gene transcription, and specifically tightens the link between acetate
metabolism and neuronal histone acetylation. Relevantly, activity-dependent increases in histone
acetylation mediate the transcription of memory-related neuroplasticity genes that function in
long-term memory. Here, we show that ACSS2 is critically important in the formation of long-term
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spatial memory in vivo, a process that has been previously demonstrated to require dynamic
increases in histone acetylation. Our results further show that ACSS2 promotes the transcription
of early response genes with key functions in neuronal plasticity and memory. To our knowledge,
this is the first demonstration that ACSS2 has a critical role in memory consolidation, and that
ACSS2 functions in dynamic gene induction in neuronal cells. Taken together, our findings
advance understanding of the molecular mechanisms involved in neuronal gene expression and
memory, and provide new insight into how metabolic activities link to epigenetic and
transcriptional regulation in the brain. Here, our results suggest a model wherein neuronal
activation in the context of learning triggers Ca2+-stimulated transcriptional events that rely on the
conversion of acetate to acetyl-CoA by ACSS2 for coordinated histone acetylation. In this view,
ACSS2 operates in a chromatin-localized salvage pathway to increase the local acetyl-CoA
concentration by recycling CoA and acetate that derive from enzymatic activity of HATs and
HDACs, respectively, to ultimately support the dynamic upregulation of immediate-early genes
that manifest memory storage (Fig. 3.11H).
Epigenetic mechanisms continue to become recognized as principal regulators of neural
function and behavior, and have been implicated in the pathophysiology of neuropsychiatric
disease, including anxiety disorders and depression. In establishing ACSS2 as a key regulator at
the interface of metabolic environment and neuronal chromatin, our study provides a novel
enzymatic target in therapies of such neurological and cognitive disorders.
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EXPERIMENTAL PROCEDURES
Cell Culture. CAD cells (Cath.-a-differentiated; generously donated from the Holzbaur Lab at the
University of Pennsylvania) were grown in DMEM:HAMS F12 (1:1), supplemented with 2mM
Glutamine, 1% penicillin/streptomycin, and 10% Fetal Bovine Serum (FBS). To induce neuronal
differentiation, sub-confluent CAD cell cultures (50-60%) were transferred to serum-free media
(DMEM:HAMS F12 (1:1) supplemented with 2mM Glutamine) and maintained in 15 cm2 culturing
dishes for 5 days. For knockdown experiments, CAD cells were infected with lentiviral hairpin
constructs (TRC collection) designed against ACL (#TRCN0000055217) or ACSS2
(#TRCN0000076124, #TRCN0000076125) in medium containing 8 mg/mL polybrene and 10%
FBS for 24 h. Cells then underwent selection in culture medium supplemented with 0.5 mg/mL
puromycin for 5 days to obtain a stably infected population.

RNA-seq. To generate libraries for RNA-seq, polyA+ RNA was was extracted using the
Dynabeads mRNA Direct kit (Ambion) according to the manufacturer’s instructions. RNA-seq
libraries for scrambled control (referred to in text as WT), shACL, and shACSS2 were made using
a ScriptSeq v2 RNA-seq Library Preparation Kit from Epicentre (now Illumina). The quantity and
quality of the libraries were assessed by BioAnalyzer (Agilent) and qPCR (Kapa Biosystems). The
multiplexed libraries were pooled and sequenced on a single lane on the Illumina NextSeq 500
platform (50bp, single-end reads). All RNA seq data was prepared for analysis as follows:
NextSeq sequencing data was demultiplexed using bcl2fastq2-v02.14.01.07. Demultiplexed
FASTQs were aligned by RNA-STAR 2.3.0.e using the genome index mm10 generated from
iGenome UCSC mm10 FASTQ genome sequence. The aligned reads were mapped to genomic
features using cufflinks-2.2.1, (-G parameter to only quantitate known features), and iGenomes
mm10 UCSC genomic transcript loci. The rRNA, mRNA, and tRNA of the mouse genome were
downloaded from the goldenPath UCSC FTP and were masked from the transcript quantification.
After quantification all data processing was done using python pandas library v.0.14.0
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Chromatin immunoprecipitation followed sequencing (ChIP-seq). CAD cells were fixed in 1%
Formaldehyde for 10 minutes and fixation was quenched with the addition of glycine to 125mM
for an additional 5 minutes. Cells were harvested by scraping from plates, and washed twice in 1x
PBS before storage at -80C. ChIP was performed as previously described (Shah, P.P., et al.
2013), except that chromatin was sheared to an average size of <500 bp using the Covaris S220
Ultrasonicator. Equal aliquots of sonicated chromatin from undifferentiated and differentiated CAD
neurons were used per immunoprecipitation reaction, and 10% of the amount was saved as
input. ACSS2 ChIPs were performed using 2000 µg of extract and 4 µg of antibody per sample;
all other ChIPs were performed using 500 µg of extract and 4 µg of antibody per sample.
Immunoprecipitation was performed using protein A Dynabeads (Life Technologies). Sequencing
libraries were prepared using NEBNext Ultra library preparation procedure, and then assessed for
quality and quantity by BioAnalyzer (Agilent) and qPCR (Kapa Biosystems). Sequencing was
performed on the Illumina NextSeq 500 platform. All ChIP-seq data was prepared for analysis as
follows: NextSeq sequencing data was demultiplexed using bcl2fastq. All reads were aligned to
the mm10 referenence genome using bowtie2.2.1. 1 alignment was allowed per read and 1
mismatch was allowed in the seed region (-N1 -k1). Reads were tabulated in fixed windows or to
genes provided in the iGenome mm10 UCSC annotations using featureCounts from the
subread1.4.6 software package. ACSS2 ChIP-seq data was normalized to input controls, while all
histone acetylation ChIP-seq data was H3-subtracted. Tracks were visualized using the UCSC
genome browser.
Western blots. Cells were lysed in buffer containing 50mM Tris pH 8.0, 0.5mM EDTA, 150mM
NaCl, 1% NP40, 1% SDS, supplemented with protease inhibitor cocktail (Life Technologies,
#78446). For subcellular fractionation experiments, the cell were processed using the subcellular
fractionation kit for cultured cells (Thermo Scientific 78840) according to the manufacturer
instructions. Protein concentration was determined by BCA protein assay (Life Technologies,
number 23227), and equal amounts of protein were used in co-immunoprecipitation experiments
or directly loaded on polyacrylamide gels. The endogenous co-immunoprecipitation (co-IP)
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experiments were performed using antibody-conjugated protein A Dynabeads (Life Technologies)
in buffer containing: 20 mM Tris, pH 8.0, 137 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 1% NP-40,
10% glycerol, with protease and phosphatase inhibitors, and 12.5 U ml−1benzonase (Novagen,
70746). Proteins or co-IP eluates were loaded and separated on 4-12% Bis-Tris polyacrylamide
gels (NuPAGE). After transfer to nitrocellulose membrane, 3% BSA in TBS supplemented with
0.1% Tween 20 (TBST) was used to block the membrane at room temperature for 1 hour.
Primary antibodies were diluted in TBST, and incubated at 4°C overnight. Primary antibodies are
listed below. The membrane was washed 3 times with TBST, each for 10 minutes, followed by
incubation of HRP-conjugated secondary antibodies at room temperature for 1 hour, in TBST.
The membrane was washed again 3 times, and imaged by Fujifilm LAS-4000 imager.
Immunofluorescence. Cells were fixed in 4% PFA in PBS for 20 minutes at room temperature.
Cells were washed twice with PBS, and permeabilized with 0.5% Triton X-100 in PBS for 10
minutes. After washing two times, cells were blocked in 10% BSA in PBS for 1 hour at room
temperature. Cells were incubated with primary antibodies in 5% BSA in PBS supplemented with
0.1% Tween 20 (PBST) overnight at 4°C. Antibodies are listed below. Then cells were washed
four times with PBST, each for 10 minutes, followed by incubation with fluorophore-conjugated
secondary antibody in 5% BSA in PBST for 1 hour at room temperature. F-actin was labeled
using Alexa Fluor® 488 Phalloidin (Thermo A12379). Cells were then washed three times in
PBST, once with PBS, and incubated with 1 µg/ml of DAPI for 5 minutes. The cells were then
washed twice with PBS, and mounted with ProLong Gold (Invitrogen). The slides were observed
and imaged using a Nikon Eclipse microscope. Microscopy settings were unchanged between
samples.
Antibodies. Antibodies included Anti-H2BK5ac (Active Motif 39124), Anti-H3 (Abcam ab1791),
Anti-H3K9ac (Abcam ab4441), Anti-H3K27ac (Abcam ab4729), Anti-H3K122ac (Abcam
ab33308), Anti-H4 (Millipore 05-858), Anti-H4K5ac (Millipore 39-584), Anti-H4K12ac (Abcam
ab1761), Anti-H4K16ac (Millipore 07-329), Anti-ACSS2 (T) (Thermo MA5-145810), Anti-ACSS2
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(CS) (Cell Signaling 3658), Anti-ACL (Proteintech 15421-1-AP), Anti-α-Tubulin (Sigma T8328),
Anti-GAPDH (Fitzgerald Industries 10R-G109A), Anti-KAT3A/CBP (Abcam ab2832).
Intracranial injection of viral vector. Adult mice (8+ weeks of age) were anesthetized with
isoflurane gas (1-5% to maintain surgical plane) and placed in a sterile field within a stereotaxic
device. Animals received an injection of bupivicaine (2.5mg/Kg) for local anesthesia before the
skin was disinfected with betadine solution and the skull exposed with a short incision using
sterile surgical equipment. Artificial tears were applied to eyes to ensure sufficient lubricating. A
small hole (about 0.5 millimeters) was be drilled in the skull over the target area using a stereotax
and a stereotactic drill. A micro-syringe filled with viral vector was inserted into the dorsal
hippocampus and slowly removed following injection (AP, -2.0mm; DV, -1.4mm; ML, +/-1.5mm;
AAV2/9.U6.shACSS2.CMV.EGFP = ACSS2 knockdown vector; AAV2/9.CMV.EGFP.polyA =
eGFP-control vector). All animals received a single dose of subcutaneous meloxicam (5 mg/kg)
as analgesia (pain medicine) at induction and one dose per day for two days post-operatively as
needed.
Object location memory (OLM) task. The OLM procedure is used to test spatial memory. The
procedure consists of a training phase and a testing phase. Prior to training, each mouse was
handled for 3 minutes a day for 3 days. During the training day, mice are placed in an arena
(approx. 1 square foot) containing 3 different objects. The objects used were a glass bottle, a
metal tower (5H x 2W x 2L inches), and a plastic cylinder. Mice were habituated to an empty
arena with a black and white striped spatial cue on the wall, followed by object exposure in three
6 minute trials with and interval of 3 minutes. The arena and objects were cleaned with 70%
EtOH between trials. After 24 hours, the individual mice were placed back in the arena used in
the testing phase. For testing, one of the objects was moved to different location in the arena.
Mice were allowed to freely explore for 5 minutes. Each session was recorded using a video
camera and time spent exploring (approaches and sniffing) each object was assessed offline.
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Contextual fear conditioning. The animal was placed in the conditioning chamber (Med
Associates) for 5 min before the onset of the unconditioned stimulus (US), a 1.5 mA of continuous
foot shock. A mild 2 sec., 1.5 mA foot shock is used as an aversive stimulus, which does not
injure the mice in any way but provides the transient, yet startling and aversive, stimulus that is
necessary for conditioning. After an additional 30 s in the chamber, the mouse was returned to its
home cage. Twenty four hours later, the mouse was tested for a freezing response to the
chamber (contextual) where training occurred. Time spent freezing in the chamber (motionless
except for respiratory movements) in the chamber was assessed for 5 consecutive minutes.
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CHAPTER 4
GENERAL DISCUSSION AND CONCLUSIONS
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Chromatin-localized acetyl-CoA metabolism functions in regulated gene expression

Epigenetic enzymes have critical roles for chromatin regulatory events in normal cellular
development and plasticity. A major question in the epigenetics field is how metabolic changes
signal to chromatin. We explored the roles of histone acetylation and methylation as putative
energy sensors, in the context of massive metabolic and transcriptional reprogramming during
cell cycle re-entry of quiescent yeast. We measured changes in global histone acetylation and
methylation by Western blot and SILAC-mass spectrometry, and used RNAseq and ChIP-seq to
examine changes in local genic modification patterns. In each of these experimental approaches
we compared histone methylation dynamics to histone acetylation, which undergoes dramatic
fluctuations in cell cycle exit and re-entry. Our results are the first comprehensive and systematic
investigation of how histone methylation responds to metabolic change in the context of cell cycle
re-entry from quiescence.
We conclude that the functions of histone methylation and histone acetylation are
remarkably distinct during nutrient-induced cell cycle return. Growth-related genes in proliferating
cells are marked with acetylation and methylation modifications associated with active
transcription. These same genes are inactive in quiescent cells, and have lost acetylation and
have lower levels of H3K4, K36, and K79 methylation. Conversely, stress genes, which are active
in quiescent cells, are enriched for acetylation and methylation. When quiescent cells are induced
to re-enter the cell cycle upon nutrient addition, acetylation is lost from stress genes and rapidly
re-established at growth genes, correlating with the massive upregulation of transcription at this
time. Accordingly, histone acetylation serves as a broad energy sensing modification that rapidly
adapts gene transcription relative to metabolic state.
Remarkably, our findings indicate that methylation functions very differently from
acetylation in re-activation into the cell cycle, and is independent of metabolic state. Instead, the
patterns of histone methylation found in quiescent cell remain unchanged for an extended period
of time, and do not increase until new histones are synthesized during the first S phase. This de-
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novo methylation occurs almost exclusively at growth genes. Thus, instead of functioning as an
energy sensor, our studies suggest that histone methylation may serve a memory mark to help
re-establish the growth gene expression program during early quiescence exit.
Our findings support the following model of gene regulation by metabolic state: direct
control of histone acetylation and global gene transcription via the key metabolite acetyl-CoA. In
yeast, during growth on glucose, the entire pool of nucleocytoplasmic acetyl-CoA that is being
used in histone acetylation is produced by catalytic Acs2p87,88. Accordingly, Acs2p is a key
enzyme positioned at the very interface of cellular carbon metabolism and chromatin structure
regulating gene expression. Relevantly, metabolic production of acetyl-CoA leading to histone
acetylation is centrally involved in cancer32,37,85,172,173, yet whether production of acetyl-CoA has a
more general role in inducible gene regulation remains a question of debate. We set out to
examine a new paradigm of transcriptional regulation, by which chromatin-localized acetyl-CoA
biosynthesis could locally support catalytic HAT activity to promote gene expression. Recent
evidence and our findings from yeast indicate that the nuclear acetyl-CoA source Acs2p may
partake in such chromatin-based gene regulation. We thus investigated the importance of its
highly conserved mammalian homolog ACSS2 for histone acetylation and gene expression, in the
fascinating context of neuronal differentiation and, in vivo, learning and memory. No such link has
been previously elucidated.
Our extensive genome-wide and functional studies in vitro in differentiating neuronal cells
provide a comprehensive understanding of mechanism underlying metabolic signaling to
chromatin, far beyond previous knowledge even in the context of cancer. Our results show that
ACSS2 indeed directly associates with chromatin, increasing nearby histone acetylation to
activate genes. In key functional data, we investigated the function of ACSS2 in vivo, and
discovered a novel role of this central metabolic enzyme in the formation of long-term spatial
memory, via upregulation of important neuronal genes. Our major results are the first evidence
that metabolic acetyl-CoA production plays a critical role in long-term memory, via neuronal gene
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regulation. These results provide an intriguing model in which ACSS2 is a chromatin-based
epigenetic factor that increases the local acetyl-CoA concentration by recycling CoA and acetate
derived from enzymatic activity of HATs and HDACs, respectively. Together, our study provides a
much-needed mechanism to explain the observed link between metabolism and epigenetic
plasticity, and further demonstrates a link to neural function. By linking acetate metabolism to
neuronal gene expression, our findings describe an entirely novel pathway in memory formation.
In the future, it will be interesting to determine the molecular targets and pathways that are
affected by ACSS2 in brain regions outside the hippocampal formation. Interestingly, in the brain,
N-Acetylaspartate (NAA) has been found to act in part as an extensive reservoir of acetate for
acetyl coenzyme A synthesis174. It will be of interest to investigate the importance of ACSS2 in
the mobilization and activation of these acetate pools, in particular after brain injury. Accordingly,
NAA metabolism and catalytic ACSS2 may support post-injury neuroenergetics, lipid synthesis,
and protein acetylation – in that case indicating novel therapeutic treatments such as acetate
supplementation following trauma.

Role of ACSS2 in neuronal histone acetylation linked to alcohol consumption
Our studies show that acetyl-CoA metabolism by ACSS2 regulates neuronal histone
acetylation and gene expression. Intriguingly, neuronal histone acetylation may therefore be
under the influence of extracellular levels of acetate, the substrate used by ACSS2 to generate
acetyl-CoA169,175. One physiological source of acetate is alcohol metabolism in hepatic cells.
Although the liver – as the site of alcohol metabolism – is particularly sensitive to alcohol
exposure, acute and chronic alcohol consumption also leads to changes in other tissues, in
particular the brain176,177. Recent advances in understanding the pleiotropic effects of ethanol
have been possible because of the development of relevant and controlled animal studies of
acute and chronic ethanol exposure178. One of the themes arising in recent studies that
investigate the mechanisms of ethanol action on target tissues is the impact of ethanol on
regulated gene expression.
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Notably, acute alcohol consumption results in highly elevated blood acetate levels,
rasining up to 5-fold179–182, and has been linked to increased histone acetylation in neuronal
tissues183. Interestingly, in alcoholics and heavy drinkers, the rate of EtOH metabolism is more
rapid, resulting in acetate plateau levels 2-fold higher in alcohol-tolerant individuals than in
controls184, suggesting greater availability of acetate as a substrate for brain metabolism.
Curiously, direct supplementation of acetate – the main product of hepatic ethanol metabolism –
increases histone acetylation in liver tissue, the heart, and the brain175. Relevantly, ACSS2 is the
only known source of nuclear acetyl-CoA deriving from the activation of nucleocytoplasmic
acetate.
Unquestionably, EtOH directly binds neuronal channel proteins and thus affects synaptic
communication and cognition, causing psychotropic effects that change along a dose
continuum185,186. Such direct manipulation of neurons may well trigger nuclear signaling events
that result in increased histone acetylation associated with ethanol consumption. However, it
remains unknown whether alcohol-induced histone acetylation might also be driven by increasing
acetyl-CoA from acetate that is activated by neuronal ACSS2, or via EtOH-triggered signaling
events that cascade into the nucleus, leading to acetylation of target genes. In order to elucidate
whether neuronal histone acetylation linked to alcohol intake is mediated by metabolic ACSS2,
we tracked the fate of isotopically labeled EtOH carbons using SILAC-based mass spec. The
SILAC approach is able to distinguish histone acetylation that originated in labeled deuterated
EtOH-d6 metabolized to acetate by hepatic alcohol dehydrogenase (ADH) and aldehyde
dehydrogenase (ALDH), from histone acetylation using other sources of acetyl-CoA (Appendix;
Figure A1, A2).
To our knowledge, our data are the first to establish that histone acetylation in the brain is
directly manipulated by products of hepatic alcohol breakdown (Appendix; Figure A3). By SILAC
mass spec, we revealed that acute alcohol intake not only contributes to dynamic chromatin
acetylation in liver and brain (Appendix; Figure A2, A3), but also drives global increases in
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particular sites of histone acetylation in both hippocampus and cortex (data not shown). Thus, our
preliminary results support the hypothesis that histone acetylation is influenced by metabolic
state, and establish a connection between alcohol intake and neuronal chromatin alterations via
liver metabolism. It will be important to investigate whether histone acetylation in other tissues is
similarly affected by hepatic ethanol metabolism. Furthermore, to firmly establish that neuronal
histone acetylation linked to alcohol ingestion is indeed mediated by ACSS2-dependent activation
of acetate originating from hepatic ADH, EtOH-d6-SILAC must be repeated in animals following
knockdown of neuronal ACSS2.
Of interest, hypothetical models of alcohol addiction that are discussed in the literature
involve histone acetylation mechanisms in the amygdala to operate in the disease 187. It has been
proposed that the first drinking episode may cause more histone acetylation due to HDAC
inhibition that results in an open chromatin structure leading to euphoric effects such as
anxiolysis187. Repeated exposure to alcohol may lead to neuroadaptive changes in epigenetic
mechanisms that translate into the development of chronic tolerance. Consequentially, cessation
from drinking may precipitate withdrawal-related anxiety due to epigenetic causes, for instance
hypoacetylation due to increased HDAC activity further condensing the chromatin structure. To
relieve these dysphoric symptoms, subjects tend to self-medicate, resulting in alcohol abuse and
dependence. Interestingly, this cycle of withdrawal leading to self-medication can be broken with
HDAC inhibitors, which promote histone acetylation and can lead to a normal behavioral state188–
190.

By the same token, modulation of ACSS2 activity may present another avenue to affect the

positive and negative states that arise due to alcohol exposure and withdrawal, and help to
further elucidate the epigenetic alterations underlying the pathogenesis of alcoholism.
ACSS2 as a therapeutic target in neuropsychiatric disorders

An important clinical implication of this work is the modulation of neuronal histone
acetylation via ACSS2 as a novel therapeutic approach in neuropsychiatry. For instance,
epigenetic regulation has been implicated in the development of post-traumatic stress disorder
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(PTSD), a prevalent yet difficult to treat disorder that is characterized by severe social and
occupational impairment191,192. Recent studies showed that development of PTSD is facilitated by
a failure to contain the biologic stress response at the time of the trauma. Specifically, PTSD has
been linked to decreased cortisol levels that can prolong the availability of norepinephrine to
synapses, resulting in the enhanced consolidation of traumatic memory192,193. In traumatized
persons, adrenergic activation and low cortisol levels will thus strongly encode the event memory,
associating it with strong feelings of distress. Following the traumatic event, unintended retrieval
of intrusive memories and the generalization of such fear memory results in worsening of
symptoms and manifestation of PTSD193.
Importantly, the initial acquisition of such traumatic long-term memory is mediated by
dynamic epigenetic mechanisms involving histone acetylation192,194. Drugs that target this process
in the ’golden hours’ are expected to be greatly useful to prevent the consolidation of traumatic
event memories and development on PTSD191. Relevantly, our studies revealed that hippocampal
ACSS2 expression is essential for cognitive plasticity and long-term memory formation. Thus, it is
reasonable to speculate that attenuation of ACSS2 using a small molecule inhibitor may be of
potential usefulness to negatively regulate cognition, in order to counteract acquisition of trauma
memory by temporarily preventing cortico-amygdala plasticity. Pharmacological targeting of
ACSS2 within hours of a traumatic event could in principle function as an amnesiac to prevent
trauma memory consolidation causing PTSD. Interestingly, modern treatment interventions for
PTSD and addiction involve extinction therapy paradigms that focus on fear extinction learning to
rescue cognitive deficits. In fact, epigenetics-based clinical trials use HDAC inhibitors in
conjunction with cognitive behavioral therapy to augment fear extinction learning 191,195.
However, the original trauma memory is not erased by fear extinction learning and newly
conditioned responses, and often followed by recurrence of disease symptoms such as intrusion
memories192,193. Theoretically, augmenting psychotherapy with medication during exposurebased ‘windows of opportunity’ could modify the trauma memory post-retrieval. Used in such re-
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exposure settings, inhibiting histone acetylation and neuronal gene expression by
pharmacological targeting of ACSS2 could prevent reconsolidation of fear memories underlying
PTSD. Similarly, in the context of substance abuse and drug addiction, ACSS2 inhibition could
prevent drug seeking behaviors if the associative memories that underlie drug addiction are
disrupted by preventing reconsolidation following re-exposure. How exactly epigenetic
mechanisms interact to regulate transcription in memory consolidation and reconsolidation will be
an exciting area of future study, and promises new therapeutic avenues and targets in
neuropsychiatry.
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Figure A1. Histone H4 acetylation labeling in SILAC with heavy EtOH
Full mass spectra of ions from the H4 peptide GKGGKGLGKGGAKR showing representative label
incorporation into single isotope heavy acetylated H4 aa 4-17 peptide 1h and 4h post EtOH-administration,
deriving from metabolized deuterated EtOH-d6 (obtained from Sigma-Aldrich, product #186414). The
appropriate injection volume is based upon the weight of the animal and the desired blood alcohol level of 300
mg/dL (calculated based upon the following formula: volume of ethanol in milliliters= [(weight of the mouse in
grams) × (desired blood alcohol level in mg/dL + 31)]/19529), and administered via intraperitoneal injection
into the lower left abdominal quadrant close to the midline at a 30° angle. In humans, blood alcohol levels of
around 300 mg/dL are associated with clinical sign and symptoms that include confusion, disorientation,
impaired balance, and slurred speech.
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Liver
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Figure A2. Heavy EtOH-SILAC – Histone acetylation labeling in liver
Visualized is the relative labeling of acetylated peptide species in a radar chart with each spoke representing
the indicated modified peptide in different treatments. The data length of a spoke is proportional to the relative
labeling of the acetylation in the indicated peptide modification variant. The three circles represent 30%, 60%
and 90% of the isotope intensity. The natural isotope distribution detected in untreated mice remains
unchanged in PBS-injected control animals. Following administration of heavy EtOH-d6, isotopic labeling of
specific histone acetylation occurs within 1h, and increases further at 4h post-injection.
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Figure A3. Heavy EtOH-SILAC – Histone acetylation labeling in cortex and hippocampus
Visualized is the relative labeling of acetylated peptide species in a radar chart with each spoke representing
the indicated modified peptide in different treatments. The data length of a spoke is proportional to the relative
labeling of the acetylation in the indicated peptide modification variant. The three circles represent 30%, 60%
and 90% of the isotope intensity. The natural isotope distribution detected in untreated mice remains
unchanged in PBS-injected control animals. Following administration of heavy EtOH-d6, isotopic labeling of
specific histone acetylation occurs within 1h, and increases further at 4h post-injection.
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